{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:41:47Z","timestamp":1792003307043,"version":"4.4.0"},"reference-count":401,"publisher":"Bentham Science Publishers Ltd.","issue":"8","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CTMC"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Diabetes is a chronic metabolic disorder having a global prevalence of nearly doubled over the last 30 years and has become one of the major health concerns worldwide. The number of adults with diabetes increased to 537 million in 2021.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Introduction:<\/jats:title>\n<jats:p>The overarching goal of diabetic research and treatment has always been to restore insulin independence and an average blood glucose level. Chemotherapeutic antidiabetic agents can manage diabetes but often show toxicity and drug resistance. Natural phytomedicines may be useful along with stem cell therapy for diabetes management. Even if the whole pancreatic organ and islet transplantation, are becoming benchmark techniques for diabetes management and control, a con-siderable scarcity of eligible donors of pancreatic tissues and organs severely limits their use. Stem cell treatment provides a bunch of possibilities for treating people with diabetes.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>For this purpose, comprehensive article searching was conducted, with relevant material obtained using search engines such as Scopus, PubMed, MEDLINE, Google, and others, using ap-propriate keywords.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Stem cell therapies, including induced pluripotent stem cells and mesenchymal stem cells, are now becoming a popular area of investigation. Recent advancements in stem cell therapy might provide a feasible treatment option. Furthermore, in recent years, some novel bioactive compounds derived from plants have demonstrated antidiabetic action with higher potency than oral hypogly-caemic medications. Recent regenerative medicine and stem cell treatment advancements might subsequently provide a feasible diabetic management option. On the other hand, medicinal herbs have been considered a better choice for the extensive treatment of diabetes.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>If proper attention is not given to control diabetes by antidiabetic chemotherapeutic agents, natural phytomedicine, and sophisticated treatment like stem cell therapy, then the lifespan of patients will be decreased, and some associated secondary problems will also arise. So, the pre-sent review attempts to discuss naturopathy as an alternative resource in combination with stem cell therapy for the progressive management of diabetes and associated disorders.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1568026623666221201150933","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T04:11:26Z","timestamp":1670213486000},"page":"649-689","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Stem Cell Therapy in Combination with Naturopathy: Current Progressive\nManagement of Diabetes and Associated Complications"],"prefix":"10.2174","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9985-3481","authenticated-orcid":true,"given":"Aloke","family":"Saha","sequence":"additional","affiliation":[{"name":"Cell and Developmental Biology Special, Department of Zoology, University of Kalyani, Kalyani, 741235, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3604-7404","authenticated-orcid":true,"given":"Asmita","family":"Samadder","sequence":"additional","affiliation":[{"name":"Cytogenetics and Molecular Biology Lab., Department of Zoology, University of Kalyani, Kalyani, 741235, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9960-6584","authenticated-orcid":true,"given":"Sisir","family":"Nandi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Global Institute of Pharmaceutical Education and Research, Kashipur,\n244713, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1471-0307.1968.tb00311.x","volume":"21","year":"1968","unstructured":"IDF NEWS Int J Dairy Technol 1968,21(2),113-113","journal-title":"Int J Dairy Technol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"Sun H.","year":"2022","unstructured":"Sun H.; Saeedi P.; Karuranga S.; Pinkepank M.; Ogurtsova K.; Duncan B.B.; Stein C.; Basit A.; Chan J.C.N.; Mbanya J.C.; Pavkov M.E.; Ramachandaran A.; Wild S.H.; James S.; Herman W.H.; Zhang P.; Bommer C.; Kuo S.; Boyko E.J.; Magliano D.J.; IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 2022,183,109119","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"Saeedi P.","year":"2019","unstructured":"Saeedi P.; Petersohn I.; Salpea P.; Malanda B.; Karuranga S.; Unwin N.; Colagiuri S.; Guariguata L.; Motala A.A.; Ogurtsova K.; Shaw J.E.; Bright D.; Williams R.; Global and Regional Diabetes Prevalence Estimates for 2019 and Projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes Research and Clinical Practice 2019,157,107843","journal-title":"Diabetes Research and Clinical Practice"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","volume":"27","author":"Wild S.","year":"2004","unstructured":"Wild S.; Roglic G.; Green A.; Sicree R.; King H.; Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004,27(5),1047-1053","journal-title":"Diabetes Care"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nrendo.2011.183","volume":"8","author":"Chen L.","year":"2012","unstructured":"Chen L.; Magliano D.J.; Zimmet P.Z.; The worldwide epidemiology of type 2 diabetes mellitus\u2014present and future perspectives. Nat Rev Endocrinol 2012,8(4),228-236","journal-title":"Nat Rev Endocrinol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.5528\/wjtm.v3.i2.84","volume":"3","author":"Samadder A.","year":"2014","unstructured":"Samadder A.; Nanotechnological approaches in diabetes treatment: A new horizon. World J Transl Med 2014,3(2),84","journal-title":"World J Transl Med"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1410053","DOI":"10.23937\/2469-570X\/1410053","volume":"5","author":"Elton M.","year":"2018","unstructured":"Elton M.; Roveena G.; Manish R.; Stem cell therapy: Recent success and continuing progress in treating diabetes. Int J Stem Cell Res Ther 2018,5(1),1410053","journal-title":"Int J Stem Cell Res Ther"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"17016","DOI":"10.1038\/nrdp.2017.16","volume":"3","author":"Katsarou A.","year":"2017","unstructured":"Katsarou A.; Gudbj&#xF6;rnsdottir S.; Rawshani A.; Dabelea D.; Bonifacio E.; Anderson B.J.; Jacobsen L.M.; Schatz D.A.; Lernmark &#xC5;.; Type 1 diabetes mellitus. Nat Rev Dis Primers 2017,3(1),17016","journal-title":"Nat Rev Dis Primers"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1542\/pir.34.5.203","volume":"34","author":"Gregory J.M.","year":"2013","unstructured":"Gregory J.M.; Moore D.J.; Simmons J.H.; Type 1 diabetes mellitus. Pediatr Rev 2013,34(5),203-215","journal-title":"Pediatr Rev"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.5001\/omj.2012.68","volume":"27","author":"Olokoba A.B.","year":"2012","unstructured":"Olokoba A.B.; Obateru O.A.; Olokoba L.B.; Type 2 diabetes mellitus: A review of current trends. Oman Med J 2012,27(4),269-273","journal-title":"Oman Med J"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1900\/RDS.2012.9.6","volume":"9","author":"Murea M.","year":"2012","unstructured":"Murea M.; Ma L.; Freedman B.I.; Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications. Rev Diabet Stud 2012,9(1),6-22","journal-title":"Rev Diabet Stud"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.csbj.2021.03.003","volume":"19","author":"Ismail L.","year":"2021","unstructured":"Ismail L.; Materwala H.; Al Kaabi J.; Association of risk factors with type 2 diabetes: A systematic review. Comput Struct Biotechnol J 2021,19,1759-1785","journal-title":"Comput Struct Biotechnol J"},{"key":"ref=13","first-page":"1066","volume":"53","year":"2004","unstructured":"Centers for Disease Control and Prevention (CDC). Prevalence of overweight and obesity among adults with diagnosed diabetes--United States, 1988-1994 and 1999-2002. MMWR Morb Mortal Wkly Rep 2004,53(45),1066-1068","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1001\/jama.300.11.1303","volume":"300","author":"Lang I.A.","year":"2008","unstructured":"Lang I.A.; Galloway T.S.; Scarlett A.; Henley W.E.; Depledge M.; Wallace R.B.; Melzer D.; Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 2008,300(11),1303-1310","journal-title":"JAMA"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1056\/NEJMp078030","volume":"356","author":"Rother K.I.","year":"2007","unstructured":"Rother K.I.; Diabetes treatment--bridging the divide. N Engl J Med 2007,356(15),1499-1501","journal-title":"N Engl J Med"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"6948","DOI":"10.4172\/2155-6156.1000198","volume":"3","author":"Sanghera D.K.","year":"2012","unstructured":"Sanghera D.K.; Blackett P.R.; Type 2 diabetes genetics: Beyond GWAS. J Diabetes Metab 2012,3(198),6948","journal-title":"J Diabetes Metab"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"114","DOI":"10.4239\/wjd.v4.i4.114","volume":"4","author":"Ali O.","year":"2013","unstructured":"Ali O.; Genetics of type 2 diabetes. World J Diabetes 2013,4(4),114-123","journal-title":"World J Diabetes"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1038\/s41598-019-39145-x","volume":"9","author":"Berumen J.","year":"2019","unstructured":"Berumen J.; Orozco L.; Betancourt-Cravioto M.; Gallardo H.; Zulueta M.; Mendizabal L.; Simon L.; Benuto R.E.; Ram&#xED;rez-Campos E.; Marin M.; Ju&#xE1;rez E.; Garc&#xED;a-Ortiz H.; Mart&#xED;nez-Hern&#xE1;ndez A.; Venegas-Vega C.; Peralta-Romero J.; Cruz M.; Tapia-Conyer R.; Influence of obesity, parental history of diabetes, and genes in type 2 diabetes: A case-control study. Sci Rep 2019,9(1),2748","journal-title":"Sci Rep"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1007\/s001250051098","volume":"41","author":"Hani E.H.","year":"1998","unstructured":"Hani E.H.; Boutin P.; Durand E.; Inoue H.; Permutt M.A.; Velho G.; Froguel P.; Missense mutations in the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2\/BIR): a meta-analysis suggests a role in the polygenic basis of Type II diabetes mellitus in Caucasians. Diabetologia 1998,41(12),1511-1515","journal-title":"Diabetologia"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1056\/NEJMra0906948","volume":"363","author":"McCarthy M.I.","year":"2010","unstructured":"McCarthy M.I.; Genomics, type 2 diabetes, and obesity. N Engl J Med 2010,363(24),2339-2350","journal-title":"N Engl J Med"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/ijo.2011.185","volume":"36","author":"Gao H.","year":"2012","unstructured":"Gao H.; Salim A.; Lee J.; Tai E.S.; van Dam R.M.; Can body fat distribution, adiponectin levels and inflammation explain differences in insulin resistance between ethnic Chinese, Malays and Asian Indians? Int J Obes 2012,36(8),1086-1093","journal-title":"Int J Obes"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2337\/dc14-2073","volume":"38","author":"Shan Z.","year":"2015","unstructured":"Shan Z.; Ma H.; Xie M.; Yan P.; Guo Y.; Bao W.; Rong Y.; Jackson C.L.; Hu F.B.; Liu L.; Sleep duration and risk of type 2 diabetes: A meta-analysis of prospective studies. Diabetes Care 2015,38(3),529-537","journal-title":"Diabetes Care"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/sleep\/32.2.200","volume":"32","author":"Patel S.R.","year":"2009","unstructured":"Patel S.R.; Zhu X.; Storfer-Isser A.; Mehra R.; Jenny N.S.; Tracy R.; Redline S.; Sleep duration and biomarkers of inflammation. Sleep 2009,32(2),200-204","journal-title":"Sleep"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.jacc.2003.07.050","volume":"43","author":"Meier-Ewert H.K.","year":"2004","unstructured":"Meier-Ewert H.K.; Ridker P.M.; Rifai N.; Regan M.M.; Price N.J.; Dinges D.F.; Mullington J.M.; Effect of sleep loss on C-Reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 2004,43(4),678-683","journal-title":"J Am Coll Cardiol"},{"key":"ref=25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172126","volume":"12","author":"Harris M.L.","year":"2017","unstructured":"Harris M.L.; Oldmeadow C.; Hure A.; Luu J.; Loxton D.; Attia J.; Stress increases the risk of type 2 diabetes onset in women: A 12-year longitudinal study using causal modelling. PLoS One 2017,12(2)","journal-title":"PLoS One"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00125-015-3860-9","volume":"59","author":"Li Y.","year":"2016","unstructured":"Li Y.; Gao X.; Winkelman J.W.; Cespedes E.M.; Jackson C.L.; Walters A.S.; Schernhammer E.; Redline S.; Hu F.B.; Association between sleeping difficulty and type 2 diabetes in women. Diabetologia 2016,59(4),719-727","journal-title":"Diabetologia"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"192ra85","DOI":"10.1126\/scitranslmed.3006055","volume":"5","author":"Kalghatgi S.","year":"2013","unstructured":"Kalghatgi S.; Spina C.S.; Costello J.C.; Liesa M.; Morones-Ramirez J.R.; Slomovic S.; Molina A.; Shirihai O.S.; Collins J.J.; Bactericidal antibiotics induce mitochondrial dysfunction and oxidative damage in Mammalian cells. Sci Transl Med 2013,5(192),192ra85","journal-title":"Sci Transl Med"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"399","DOI":"10.4093\/dmj.2012.36.6.399","volume":"36","author":"Chang S.A.","year":"2012","unstructured":"Chang S.A.; Smoking and type 2 diabetes mellitus. Diabetes Metab J 2012,36(6),399-403","journal-title":"Diabetes Metab J"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S2213-8587(14)70184-6","volume":"3","author":"Ye Z.","year":"2015","unstructured":"Ye Z.; Sharp S.J.; Burgess S.; Scott R.A.; Imamura F.; Langenberg C.; Wareham N.J.; Forouhi N.G.; Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol 2015,3(1),35-42","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"836","DOI":"10.2215\/CJN.08001109","volume":"5","author":"Lin J.","year":"2010","unstructured":"Lin J.; Hu F.B.; Curhan G.C.; Associations of diet with albuminuria and kidney function decline. Clin J Am Soc Nephrol 2010,5(5),836-843","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.diabres.2017.11.020","volume":"136","author":"Li Y.","year":"2018","unstructured":"Li Y.; Chen J.; Duan L.; Li S.; Effect of vitamin K2 on type 2 diabetes mellitus: A review. Diabetes Res Clin Pract 2018,136,39-51","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002566","volume":"15","author":"Lu L.","year":"2018","unstructured":"Lu L.; Bennett D.A.; Millwood I.Y.; Parish S.; McCarthy M.I.; Mahajan A.; Lin X.; Bragg F.; Guo Y.; Holmes M.V.; Afzal S.; Nordestgaard B.G.; Bian Z.; Hill M.; Walters R.G.; Li L.; Chen Z.; Clarke R.; Association of vitamin D with risk of type 2 diabetes: A Mendelian randomisation study in European and Chinese adults. PLoS Med 2018,15(5)","journal-title":"PLoS Med"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"872","DOI":"10.2337\/dc16-2302","volume":"40","author":"Gulseth H.L.","year":"2017","unstructured":"Gulseth H.L.; Wium C.; Angel K.; Eriksen E.F.; Birkeland K.I.; Effects of Vitamin D supplementation on insulin sensitivity and insulin secretion in subjects with type 2 diabetes and vitamin D deficiency: A randomized controlled trial. Diabetes Care 2017,40(7),872-878","journal-title":"Diabetes Care"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1093\/aje\/kwx156","volume":"186","author":"Talaei M.","year":"2017","unstructured":"Talaei M.; Wang Y.L.; Yuan J.M.; Pan A.; Koh W.P.; Meat, dietary heme iron, and risk of Type 2 Diabetes Mellitus. Am J Epidemiol 2017,186(7),824-833","journal-title":"Am J Epidemiol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"S154","DOI":"10.1093\/advances\/nmy107","volume":"10","author":"Alvarez-Bueno C.","year":"2019","unstructured":"Alvarez-Bueno C.; Cavero-Redondo I.; Martinez-Vizcaino V.; Sotos-Prieto M.; Ruiz J.R.; Gil A.; Effects of milk and dairy product consumption on Type 2 Diabetes: Overview of systematic reviews and meta-analyses. Adv Nutr 2019,10(Suppl. 2),S154-S163","journal-title":"Adv Nutr"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1146\/annurev-nutr-071816-064941","volume":"37","author":"Grosso G.","year":"2017","unstructured":"Grosso G.; Godos J.; Galvano F.; Giovannucci E.L.; Coffee, caffeine, and health outcomes: An umbrella review. Annu Rev Nutr 2017,37(1),131-156","journal-title":"Annu Rev Nutr"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3390\/nu8110739","volume":"8","author":"Fang X.","year":"2016","unstructured":"Fang X.; Han H.; Li M.; Liang C.; Fan Z.; Aaseth J.; He J.; Montgomery S.; Cao Y.; Dose-response relationship between dietary magnesium intake and risk of type 2 diabetes mellitus: A systematic review and meta-regression analysis of prospective cohort studies. Nutrients 2016,8(11),739","journal-title":"Nutrients"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.3390\/molecules22101664","volume":"22","author":"Quansah D.","year":"2017","unstructured":"Quansah D.; Ha K.; Jun S.; Kim S.A.; Shin S.; Wie G.A.; Joung H.; Associations of dietary antioxidants and risk of Type 2 Diabetes: Data from the 2007-2012 Korea National Health and Nutrition Examination Survey. Molecules 2017,22(10),1664","journal-title":"Molecules"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1471-2156-15-69","volume":"15","author":"Villegas R.","year":"2014","unstructured":"Villegas R.; Goodloe R.J.; McClellan B.E.; Boston J.; Crawford D.C.; Gene-carbohydrate and gene-fiber interactions and type 2 diabetes in diverse populations from the National Health and Nutrition Examination Surveys (NHANES) as part of the Epidemiologic Architecture for Genes Linked to Environment (EAGLE) study. BMC Genet 2014,15(1),69","journal-title":"BMC Genet"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"S214","DOI":"10.1017\/S0007114512001602","volume":"107","author":"Wu J.H.Y.","year":"2012","unstructured":"Wu J.H.Y.; Micha R.; Imamura F.; Pan A.; Biggs M.L.; Ajaz O.; Djousse L.; Hu F.B.; Mozaffarian D.; Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysis. Br J Nutr 2012,107(Suppl. 2),S214-S227","journal-title":"Br J Nutr"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2174\/1389450123666211216150355","volume":"23","author":"Dey S.","year":"2022","unstructured":"Dey S.; Samadder A.; Nandi S.; Exploring current role of nanotechnology used in food processing industry to control food additives and their biochemical mechanisms. Curr Drug Targets 2022,23(5),513-539","journal-title":"Curr Drug Targets"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"105586","DOI":"10.1016\/j.ejps.2020.105586","volume":"156","author":"Dey R.","year":"2021","unstructured":"Dey R.; Nandi S.; Samadder A.; Pelargonidin mediated selective activation of p53 and parp proteins in preventing food additive induced genotoxicity: An in vivo coupled in silico molecular docking study. Eur J Pharm Sci 2021,156,105586","journal-title":"Eur J Pharm Sci"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s11938-017-0151-1","volume":"15","author":"Piper M.S.","year":"2017","unstructured":"Piper M.S.; Saad R.J.; Diabetes mellitus and the colon. Curr Treat Options Gastroenterol 2017,15(4),460-474","journal-title":"Curr Treat Options Gastroenterol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1101\/gad.346973.120","volume":"35","author":"Novak J.S.S.","year":"2021","unstructured":"Novak J.S.S.; Baksh S.C.; Fuchs E.; Dietary interventions as regulators of stem cell behavior in homeostasis and disease. Genes Dev 2021,35(3-4),199-211","journal-title":"Genes Dev"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s13340-016-0299-2","volume":"8","author":"Kido Y.","year":"2017","unstructured":"Kido Y.; Gene-environment interaction in type 2 diabetes. Diabetol Int 2017,8(1),7-13","journal-title":"Diabetol Int"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.2337\/db11-1314","volume":"61","author":"Ding G.L.","year":"2012","unstructured":"Ding G.L.; Wang F.F.; Shu J.; Tian S.; Jiang Y.; Zhang D.; Wang N.; Luo Q.; Zhang Y.; Jin F.; Leung P.C.K.; Sheng J.Z.; Huang H.F.; Transgenerational glucose intolerance with Igf2\/H19 epigenetic alterations in mouse islet induced by intrauterine hyperglycemia. Diabetes 2012,61(5),1133-1142","journal-title":"Diabetes"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"5449","DOI":"10.1073\/pnas.1019007108","volume":"108","author":"Sandovici I.","year":"2011","unstructured":"Sandovici I.; Smith N.H.; Nitert M.D.; Ackers-Johnson M.; Uribe-Lewis S.; Ito Y.; Jones R.H.; Marquez V.E.; Cairns W.; Tadayyon M.; O\u2019Neill L.P.; Murrell A.; Ling C.; Const&#xE2;ncia M.; Ozanne S.E.; Maternal diet and aging alter the epigenetic control of a promoter-enhancer interaction at the Hnf4a gene in rat pancreatic islets. Proc Natl Acad Sci USA 2011,108(13),5449-5454","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"13611","DOI":"10.1074\/jbc.M800128200","volume":"283","author":"Raychaudhuri N.","year":"2008","unstructured":"Raychaudhuri N.; Raychaudhuri S.; Thamotharan M.; Devaskar S.U.; Histone code modifications repress glucose transporter 4 expression in the intrauterine growth-restricted offspring. J Biol Chem 2008,283(20),13611-13626","journal-title":"J Biol Chem"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1146\/annurev-pathmechdis-012418-012818","volume":"14","author":"Ogino S.","year":"2019","unstructured":"Ogino S.; Nowak J.A.; Hamada T.; Milner D.A.; Nishihara R.; Insights into pathogenic interactions among environment, host, and tumor at the crossroads of molecular pathology and epidemiology. Annu Rev Pathol 2019,14(1),83-103","journal-title":"Annu Rev Pathol"},{"key":"ref=50","first-page":"19","volume":"26","author":"Wilcox G.","year":"2005","unstructured":"Wilcox G.; Insulin and insulin resistance. Clin Biochem Rev 2005,26(2),19-39","journal-title":"Clin Biochem Rev"},{"key":"ref=51","first-page":"993","volume":"73","author":"Gupta B.B.P.","year":"1997","unstructured":"Gupta B.B.P.; Mechanism of insulin action. Curr Sci 1997,73(11),993-1003","journal-title":"Curr Sci"},{"key":"ref=52","first-page":"489","volume":"70","author":"Mayfield J.A.","year":"2004","unstructured":"Mayfield J.A.; White R.D.; Insulin therapy for type 2 diabetes: Rescue, augmentation, and replacement of beta-cell function. Am Fam Phys 2004,70(3),489-500","journal-title":"Am Fam Phys"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3810\/pgm.2011.07.2307","volume":"123","author":"Unger J.","year":"2011","unstructured":"Unger J.; Parkin C.; Hypoglycemia in insulin-treated diabetes: A case for increased vigilance. Postgrad Med 2011,123(4),81-91","journal-title":"Postgrad Med"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2165\/00128071-200708010-00003","volume":"8","author":"Radermecker R.P.","year":"2007","unstructured":"Radermecker R.P.; Pi&#xE9;rard G.E.; Scheen A.J.; Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs. Am J Clin Dermatol 2007,8(1),21-28","journal-title":"Am J Clin Dermatol"},{"key":"ref=55","first-page":"276","volume":"62","author":"Rybicka M.","year":"2011","unstructured":"Rybicka M.; Krysiak R.; Okopie\u0144 B.; The dawn phenomenon and the Somogyi effect-two phenomena of morning hyperglycaemia. Endokrynol Pol 2011,62(3),276-284","journal-title":"Endokrynol Pol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1042\/CS20110386","volume":"122","author":"Viollet B.","year":"2012","unstructured":"Viollet B.; Guigas B.; Garcia N.S.; Leclerc J.; Foretz M.; Andreelli F.; Cellular and molecular mechanisms of metformin: An overview. Clin Sci (Lond) 2012,122(6),253-270","journal-title":"Clin Sci (Lond)"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"E182","DOI":"10.1152\/ajpendo.00272.2005","volume":"291","author":"Collier C.A.","year":"2006","unstructured":"Collier C.A.; Bruce C.R.; Smith A.C.; Lopaschuk G.; Dyck D.J.; Metformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscle. Am J Physiol Endocrinol Metab 2006,291(1),E182-E189","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s40520-016-0546-1","volume":"29","author":"Fogelman Y.","year":"2017","unstructured":"Fogelman Y.; Kitai E.; Blumberg G.; Golan-Cohen A.; Rapoport M.; Carmeli E.; Vitamin B12 screening in metformin-treated diabetics in primary care: Were elderly patients less likely to be tested? Aging Clin Exp Res 2017,29(2),135-139","journal-title":"Aging Clin Exp Res"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/2042018814558242","volume":"6","author":"Harris K.B.","year":"2015","unstructured":"Harris K.B.; McCarty D.J.; Efficacy and tolerability of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus. Ther Adv Endocrinol Metab 2015,6(1),3-18","journal-title":"Ther Adv Endocrinol Metab"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2174\/157488412800958686","volume":"7","author":"Derosa G.","year":"2012","unstructured":"Derosa G.; Maffioli P.; GLP-1 agonists exenatide and liraglutide: A review about their safety and efficacy. Curr Clin Pharmacol 2012,7(3),214-228","journal-title":"Curr Clin Pharmacol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"S368","DOI":"10.2337\/diabetes.51.2007.S368","volume":"51","author":"Proks P.","year":"2002","unstructured":"Proks P.; Reimann F.; Green N.; Gribble F.; Ashcroft F.; Sulfonylurea stimulation of insulin secretion. Diabetes 2002,51(Suppl. 3),S368-S376","journal-title":"Diabetes"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/MED.0b013e3283444ba0","volume":"18","author":"Chiniwala N.","year":"2011","unstructured":"Chiniwala N.; Jabbour S.; Management of diabetes mellitus in the elderly. Curr Opin Endocrinol Diabetes Obes 2011,18(2),148-152","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0895-4356(97)00024-3","volume":"50","author":"Van Staa T.","year":"1997","unstructured":"Van Staa T.; Abenhaim L.; Monette J.; Rates of hypoglycemia in users of sulfonylureas. J Clin Epidemiol 1997,50(6),735-741","journal-title":"J Clin Epidemiol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/j.1532-5415.1996.tb03729.x","volume":"44","author":"Shorr R.I.","year":"1996","unstructured":"Shorr R.I.; Ray W.A.; Daugherty J.R.; Griffin M.R.; Individual sulfonylureas and serious hypoglycemia in older people. J Am Geriatr Soc 1996,44(7),751-755","journal-title":"J Am Geriatr Soc"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"601","DOI":"10.2165\/00002018-200528070-00004","volume":"28","author":"Scheen A.J.","year":"2005","unstructured":"Scheen A.J.; Drug interactions of clinical importance with antihyperglycaemic agents. Drug Saf 2005,28(7),601-631","journal-title":"Drug Saf"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/14656566.2020.1853100","volume":"22","author":"Hurren K.M.","year":"2021","unstructured":"Hurren K.M.; Dunham M.W.; Are thiazolidinediones a preferred drug treatment for type 2 diabetes? Expert Opin Pharmacother 2021,22(2),131-133","journal-title":"Expert Opin Pharmacother"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1056\/NEJMra041001","volume":"351","author":"Yki-J&#xE4;rvinen H.","year":"2004","unstructured":"Yki-J&#xE4;rvinen H.; Thiazolidinediones. N Engl J Med 2004,351(11),1106-1118","journal-title":"N Engl J Med"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/S0140-6736(06)69703-1","volume":"368","author":"Yoon K.H.","year":"2006","unstructured":"Yoon K.H.; Lee J.H.; Kim J.W.; Cho J.H.; Choi Y.H.; Ko S.H.; Zimmet P.; Son H.Y.; Epidemic obesity and type 2 diabetes in Asia. Lancet 2006,368(9548),1681-1688","journal-title":"Lancet"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S0002-9343(99)80343-X","volume":"98","author":"Coniff R.F.","year":"1995","unstructured":"Coniff R.F.; Shapiro J.A.; Seaton T.B.; Bray G.A.; Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus. Am J Med 1995,98(5),443-451","journal-title":"Am J Med"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"899","DOI":"10.5114\/aoms.2012.31621","volume":"5","author":"Derosa G.","year":"2012","unstructured":"Derosa G.; Maffioli P.; Mini-Special Issue paper Management of diabetic patients with hypoglycemic agents &#x3B1;-glucosidase inhibitors and their use in clinical practice. Arch Med Sci 2012,5(5),899-906","journal-title":"Arch Med Sci"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/S0140-6736(09)60222-1","volume":"373","author":"Kawamori R.","year":"2009","unstructured":"Kawamori R.; Tajima N.; Iwamoto Y.; Kashiwagi A.; Shimamoto K.; Kaku K.; Voglibose for prevention of type 2 diabetes mellitus: A randomised, double-blind trial in Japanese individuals with impaired glucose tolerance. Lancet 2009,373(9675),1607-1614","journal-title":"Lancet"},{"key":"ref=72","first-page":"509","volume":"35","author":"Pathak R.","year":"2010","unstructured":"Pathak R.; Bridgeman M.B.; Dipeptidyl Peptidase-4 (DPP-4) inhibitors in the management of diabetes. PandT 2010,35(9),509-513","journal-title":"PandT"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1185\/030079906X162746","volume":"23","author":"Pratley R.E.","year":"2007","unstructured":"Pratley R.E.; Salsali A.; Inhibition of DPP-4: A new therapeutic approach for the treatment of type 2 diabetes. Curr Med Res Opin 2007,23(4),919-931","journal-title":"Curr Med Res Opin"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1111\/j.1742-1241.2006.01178.x","volume":"60","author":"Barnett A.","year":"2006","unstructured":"Barnett A.; DPP-4 inhibitors and their potential role in the management of type 2 diabetes. Int J Clin Pract 2006,60(11),1454-1470","journal-title":"Int J Clin Pract"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/phar.1303","volume":"33","author":"Riser Taylor S.","year":"2013","unstructured":"Riser Taylor S.; Harris K.B.; The clinical efficacy and safety of sodium glucose cotransporter-2 inhibitors in adults with type 2 diabetes mellitus. Pharmacotherapy 2013,33(9),984-999","journal-title":"Pharmacotherapy"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s11655-011-0810-3","volume":"17","author":"Prabhakar P.K.","year":"2011","unstructured":"Prabhakar P.K.; Doble M.; Mechanism of action of natural products used in the treatment of diabetes mellitus. Chin J Integr Med 2011,17(8),563-574","journal-title":"Chin J Integr Med"},{"key":"ref=77","first-page":"1116","volume":"3","author":"Kumar K.","year":"2014","unstructured":"Kumar K.; Fateh V.; Verma B.; Pandey S.; Some herbal drugs used for treatment of diabetes. Int J Res Dev Pharm L Sci 2014,3(5),1116-1120","journal-title":"Int J Res Dev Pharm L Sci"},{"key":"ref=78","author":"Wachtel-Galor S.","year":"2011","unstructured":"Wachtel-Galor S.; Benzie I.F.F.; Herbal Medicine: An introduction to its history, usage, regulation, current trends, and research needs. Herbal Medicine: Biomolecular and Clinical Aspects 2011","journal-title":"Herbal Medicine: Biomolecular and Clinical Aspects"},{"key":"ref=79","first-page":"1","volume":"5","author":"Gupta R.","year":"2007","unstructured":"Gupta R.; Bajpai K.G.; Johri S.; Saxena A.M.; An overview of Indian novel traditional medicinal plants with anti-diabetic potentials. Afr J Tradit Complement Altern Med 2007,5(1),1-17","journal-title":"Afr J Tradit Complement Altern Med"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1021\/cr9900026","volume":"100","author":"Peczuh M.W.","year":"2000","unstructured":"Peczuh M.W.; Hamilton A.D.; Peptide and protein recognition by designed molecules. Chem Rev 2000,100(7),2479-2494","journal-title":"Chem Rev"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ejphar.2013.06.009","volume":"714","author":"Saha S.K.","year":"2013","unstructured":"Saha S.K.; Khuda-Bukhsh A.R.; Molecular approaches towards development of purified natural products and their structurally known derivatives as efficient anti-cancer drugs: Current trends. Eur J Pharmacol 2013,714(1-3),239-248","journal-title":"Eur J Pharmacol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/(SICI)1521-3773(19990301)38:5<643:AID-ANIE643>3.0.CO;2-G","volume":"38","author":"Henkel T.","year":"1999","unstructured":"Henkel T.; Brunne R.M.; M&#xFC;ller H.; Reichel F.; Statistical investigation into the structural complementarity of natural products and synthetic compounds. Angew Chem Int Ed 1999,38(5),643-647","journal-title":"Angew Chem Int Ed"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/978-94-007-5500-0_14","author":"Pati R.","year":"2013","unstructured":"Pati R.; Muthukumar M.; Genetic Transformation of Bael (Aegle marmelos Corr.). Biotechnology of Neglected and Underutilized Crops 2013,343-365","journal-title":"Biotechnology of Neglected and Underutilized Crops"},{"key":"ref=84","first-page":"1085","volume":"4","author":"Prajapat R.","year":"2012","unstructured":"Prajapat R.; Gupta V.; Soni B.; Choudhary D.; Ram V.; Bh A.; Ari. Extraction and isolation of marmelosin from Aegle marmelos, synthesis and evaluation of their derivative as antidiabetic agent. Pharm Lett 2012,4,1085-1092","journal-title":"Pharm Lett"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.foodchem.2009.01.008","volume":"115","author":"Li J.","year":"2009","unstructured":"Li J.; Zhang M.; Zheng T.; The in vitro antioxidant activity of lotus germ oil from supercritical fluid carbon dioxide extraction. Food Chem 2009,115(3),939-944","journal-title":"Food Chem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.intimp.2015.11.036","volume":"30","author":"Bodduluru L.N.","year":"2016","unstructured":"Bodduluru L.N.; Kasala E.R.; Madhana R.M.; Barua C.C.; Hussain M.I.; Haloi P.; Borah P.; Naringenin ameliorates inflammation and cell proliferation in benzo(a)pyrene induced pulmonary carcinogenesis by modulating CYP1A1, NF&#x3BA;B and PCNA expression. Int Immunopharmacol 2016,30,102-110","journal-title":"Int Immunopharmacol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/molecules24010119","volume":"24","author":"Marrelli M.","year":"2018","unstructured":"Marrelli M.; Amodeo V.; Statti G.; Conforti F.; Biological properties and bioactive components of Allium cepa L.: focus on potential benefits in the treatment of obesity and related comorbidities. Molecules 2018,24(1),119","journal-title":"Molecules"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3390\/biology9090252","volume":"9","author":"Tran N.","year":"2020","unstructured":"Tran N.; Pham B.; Le L.; Bioactive compounds in anti-diabetic plants: From herbal medicine to modern drug discovery. Biology (Basel) 2020,9(9),252","journal-title":"Biology (Basel)"},{"key":"ref=89","doi-asserted-by":"publisher","DOI":"10.4172\/2161-0509.1000102","volume":"1","author":"Aggarwal N.","year":"2011","unstructured":"Aggarwal N.; Shishu A.; Review of recent investigations on medicinal herbs possessing anti-diabetic properties. J Nutr Disord Ther 2011,1(1)","journal-title":"J Nutr Disord Ther"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"60675","DOI":"10.5812\/ircmj.60675","volume":"20","author":"Faroughi F.","year":"2018","unstructured":"Faroughi F.; Mohammad-Alizadeh Charandabi S.; Javadzadeh Y.; Mirghafourvand M.; Effects of garlic pill on blood glucose level in borderline gestational diabetes mellitus: A randomized controlled trial. Iran Red Crescent Med J 2018,20(7),60675","journal-title":"Iran Red Crescent Med J"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"5555","DOI":"10.3390\/app9245555","volume":"9","author":"Sharifi-Rad J.","year":"2019","unstructured":"Sharifi-Rad J.; Cristina Cirone Silva N.; Jantwal A.; Bhatt D.I.; Sharopov F.; Cho W.; Taheri Y.; Martins N.; Therapeutic potential of allicin-rich garlic preparations: Emphasis on clinical evidence toward upcoming drugs formulation. Appl Sci (Basel) 2019,9(24),5555","journal-title":"Appl Sci (Basel)"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"872","DOI":"10.3390\/nu12030872","volume":"12","author":"El-Saber Batiha G.","year":"2020","unstructured":"El-Saber Batiha G.; Magdy Beshbishy A.; G Wasef L.; Elewa, Y.H.A.; A Al-Sagan, A.; Abd El-Hack, M.E.; Taha, A.E.; M Abd-Elhakim, Y.; Prasad Devkota, H. Chemical constituents and pharmacological activities of garlic (Allium sativum L.): A review. Nutrients 2020,12(3),872","journal-title":"Nutrients"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"377","DOI":"10.4103\/0253-7613.96343","volume":"44","author":"Nugroho A.","year":"2012","unstructured":"Nugroho A.; Warditiani N.K.; Pramono S.; Andrie M.; Siswanto E.; Lukitaningsih E.; Antidiabetic and antihiperlipidemic effect of Andrographis paniculata (Burm. f.) Nees and andrographolide in high-fructose-fat-fed rats. Indian J Pharmacol 2012,44(3),377-381","journal-title":"Indian J Pharmacol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"82","DOI":"10.20510\/ukjpb\/4\/i1\/90385","volume":"4","author":"Preeti S.","year":"2016","unstructured":"Preeti S.; Kamlesh S.; Pushpa P.; Shashikant C.; Sahu R.K.; Roy A.; Approach to phytochemistry and mechaniasm of action of plants having antidiabetic activity. UK J Pharmaceut Biosci 2016,4(1),82-120","journal-title":"UK J Pharmaceut Biosci"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11596-018-1841-1","volume":"38","author":"Qi C.","year":"2018","unstructured":"Qi C.; Zhou Q.; Yuan Z.; Luo Z.; Dai C.; Zhu H.; Chen C.; Xue Y.; Wang J.; Wang Y.; Liu Y.; Xiang M.; Sun W.; Zhang J.; Zhang Y.; Kinsenoside: A promising bioactive compound from anoectochilus species. Curr Med Sci 2018,38(1),11-18","journal-title":"Curr Med Sci"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5478\/MSL.2015.6.2.48","volume":"6","author":"Rehman S.U.","year":"2015","unstructured":"Rehman S.U.; Kim S.; Choi M.S.; Luo Z.; Yao G.; Xue Y.; Zhang Y.; Yoo H.H.; Evaluation of metabolic stability of kinsenoside, an antidiabetic candidate, in rat and human liver microsomes. Mass Spectrom Lett 2015,6(2),48-51","journal-title":"Mass Spectrom Lett"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jep.2007.05.022","volume":"114","author":"Zhang Y.","year":"2007","unstructured":"Zhang Y.; Cai J.; Ruan H.; Pi H.; Wu J.; Antihyperglycemic activity of kinsenoside, a high yielding constituent from Anoectochilus roxburghii in streptozotocin diabetic rats. J Ethnopharmacol 2007,114(2),141-145","journal-title":"J Ethnopharmacol"},{"key":"ref=98","first-page":"65","volume":"1","author":"Patel B.H.","year":"2014","unstructured":"Patel B.H.; Mandot A.A.; Jha P.K.; Extraction, characterization and application of Azadirachta indica leaves for development of hygienic lycra filament. J Int Acad Res Multidisciplin 2014,1(12),65-84","journal-title":"J Int Acad Res Multidisciplin"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3164\/jcbn.40.163","volume":"40","author":"Modak M.","year":"2007","unstructured":"Modak M.; Dixit P.; Londhe J.; Ghaskadbi S.; Devasagayam T.P.A.; Indian herbs and herbal drugs used for the treatment of diabetes. J Clin Biochem Nutr 2007,40(3),163-173","journal-title":"J Clin Biochem Nutr"},{"key":"ref=100","first-page":"515","volume":"3","author":"Paari E.","year":"2019","unstructured":"Paari E.; Pari L.; Role of some phytochemicals in the management of Diabetes Mellitus: A review. JMPR 2019,3(4),515-520","journal-title":"JMPR"},{"key":"ref=101","first-page":"158","volume":"4","author":"Chakrabarti R.","year":"2011","unstructured":"Chakrabarti R.; Bhavtaran S.; Narendra P.; Varghese N.; Vanchhawbg L.; Shihabudeen H.M.S.; Thirumurgan K.; Dipeptidyl Peptidase-IV inhibitory activity of Berberis aristata. J Nat Prod 2011,4,158-163","journal-title":"J Nat Prod"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"018","DOI":"10.17352\/ijcem.000024","volume":"31","author":"Mohanty I.","year":"2017","unstructured":"Mohanty I.; Kumar S.; Rajesh S.; Dipeptidyl Peptidase IV inhibitory activity of Berberine and Mangiferin: An in silico approach. Int J Clin Endocrinol Metab 2017,31(1),018-022","journal-title":"Int J Clin Endocrinol Metab"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.metabol.2008.01.013","volume":"57","author":"Yin J.","year":"2008","unstructured":"Yin J.; Xing H.; Ye J.; Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism 2008,57(5),712-717","journal-title":"Metabolism"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fphar.2019.00019","volume":"10","author":"Tian X.","year":"2019","unstructured":"Tian X.; Liu F.; Li Z.; Lin Y.; Liu H.; Hu P.; Chen M.; Sun Z.; Xu Z.; Zhang Y.; Han L.; Zhang Y.; Pan G.; Huang C.; Enhanced anti-diabetic effect of Berberine Combined With Timosaponin B2 in Goto-Kakizaki rats, associated with increased variety and exposure of effective substances through intestinal absorption. Front Pharmacol 2019,10,19","journal-title":"Front Pharmacol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jep.2003.12.013","volume":"91","author":"Pari L.","year":"2004","unstructured":"Pari L.; Satheesh M.A.; Antidiabetic activity of Boerhaavia diffusa L.: effect on hepatic key enzymes in experimental diabetes. J Ethnopharmacol 2004,91(1),109-113","journal-title":"J Ethnopharmacol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/808302","volume":"2014","author":"Mishra S.","year":"2014","unstructured":"Mishra S.; Aeri V.; Gaur P.K.; Jachak S.M.; Phytochemical, therapeutic, and ethnopharmacological overview for a traditionally important herb: Boerhavia diffusa Linn. BioMed Res Int 2014,2014,1-19","journal-title":"BioMed Res Int"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.fct.2019.01.037","volume":"125","author":"Bule M.","year":"2019","unstructured":"Bule M.; Abdurahman A.; Nikfar S.; Abdollahi M.; Amini M.; Antidiabetic effect of quercetin: A systematic review and meta-analysis of animal studies. Food Chem Toxicol 2019,125,494-502","journal-title":"Food Chem Toxicol"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S2221-1691(11)60052-X","volume":"1","author":"Thirumalai T.","year":"2011","unstructured":"Thirumalai T.; Therasa S.V.; Elumalai E.K.; David E.; Hypoglycemic effect of Brassica juncea (seeds) on streptozotocin induced diabetic male albino rat. Asian Pac J Trop Biomed 2011,1(4),323-325","journal-title":"Asian Pac J Trop Biomed"},{"key":"ref=109","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aah4477","volume":"9","author":"Axelsson A.S.","year":"2017","unstructured":"Axelsson A.S.; Tubbs E.; Mecham B.; Chacko S.; Nenonen H.A.; Tang Y.; Fahey J.W.; Derry J.M.J.; Wollheim C.B.; Wierup N.; Haymond M.W.; Friend S.H.; Mulder H.; Rosengren A.H.; Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes. Sci Transl Med 2017,9(394)","journal-title":"Sci Transl Med"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1016\/S2095-3119(12)60185-3","volume":"11","author":"Gu Z.","year":"2012","unstructured":"Gu Z.; Guo Q.; Gu Y.; Factors influencing glucoraphanin and sulforaphane formation in brassica plants: A review. J Integr Agric 2012,11(11),1804-1816","journal-title":"J Integr Agric"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0378-8741(91)90158-A","volume":"33","author":"Naik S.R.","year":"1991","unstructured":"Naik S.R.; Filho J.M.B.; Dhuley J.N.; Deshmukh V.; Probable mechanism of hypoglycemic activity of bassic acid, a natural product isolated from Bumelia sartorum. J Ethnopharmacol 1991,33(1-2),37-44","journal-title":"J Ethnopharmacol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"121","DOI":"10.5455\/jeim.160615.rw.012","volume":"5","author":"Mohammed A.","year":"2015","unstructured":"Mohammed A.; Kumar D.; Rizvi S.; Emergence of traditional antidiabetic treatments as starting points for development of modern medicine. J Exp Integr Med 2015,5(3),121","journal-title":"J Exp Integr Med"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4103\/2231-4040.90874","volume":"2","author":"Pal D.","year":"2011","unstructured":"Pal D.; Sachan N.; Ghosh A.K.; Mishra P.; Biological activities and medicinal properties of Cajanus cajan (L.). Millsp J Adv Pharm Technol Res 2011,2(4),207-214","journal-title":"Millsp J Adv Pharm Technol Res"},{"key":"ref=114","first-page":"81","volume":"1","author":"Ezike A.C.","year":"2010","unstructured":"Ezike A.C.; Akah P.A.; Okoli C.C.; Okpala C.B.; Experimental evidence for the antidiabetic activity of Cajanus cajan leaves in rats. J Basic Clin Pharm 2010,1(2),81-84","journal-title":"J Basic Clin Pharm"},{"key":"ref=115","first-page":"195","volume":"157","author":"Danese C.","year":"2006","unstructured":"Danese C.; Esposito D.; D\u2019Alfonso V.; Cirene M.; Ambrosino M.; Colotto M.; Plasma glucose level decreases as collateral effect of fermented papaya preparation use. Clin Ter 2006,157(3),195-198","journal-title":"Clin Ter"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"227","DOI":"10.34297\/AJBSR.2019.05.000917","volume":"5","author":"Airaodion A.","year":"2019","unstructured":"Airaodion A.; Antidiabetic effect of ethanolic extract of Carica papaya leaves in alloxan-induced diabetic rats. Am J Biomed Sci Res 2019,5(3),227-234","journal-title":"Am J Biomed Sci Res"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"19","DOI":"10.5281\/ZENODO.1014019","author":"Kondratiuk T.","year":"2017","unstructured":"Kondratiuk T.; Beregova T.; Ostapchenko L.; Srivastava A.K.; Singh V.K.; Elbayaa R.Y.; Abdelwahab I.A.; Youssef F.S.; Ashour M.L.; Antimicrobial activity of papain. Antimicrobial activity of natural substances 2017,19-34","journal-title":"Antimicrobial activity of natural substances"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.3390\/molecules26123625","volume":"26","author":"Hajlaoui H.","year":"2021","unstructured":"Hajlaoui H.; Arraouadi S.; Noumi E.; Aouadi K.; Adnan M.; Khan M.A.; Kadri A.; Snoussi M.; Antimicrobial, antioxidant, anti-acetylcholinesterase, antidiabetic, and pharmacokinetic properties of Carum carvi L. and Coriandrum sativum L. essential oils alone and in combination. Molecules 2021,26(12),3625","journal-title":"Molecules"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.3390\/biom11121803","volume":"11","author":"Bouyahya A.","year":"2021","unstructured":"Bouyahya A.; Mechchate H.; Benali T.; Ghchime R.; Charfi S.; Balahbib A.; Burkov P.; Shariati M.A.; Lorenzo J.M.; Omari N.E.; Health benefits and pharmacological properties of Carvone. Biomolecules 2021,11(12),1803","journal-title":"Biomolecules"},{"key":"ref=120","first-page":"3417","volume":"7","author":"Girme A.","year":"2018","unstructured":"Girme A.; Gaikar N.; Saste G.; Kunkulol R.; Chemical studies on antidiabetic botanical drug: Cassia auriculata. J Pharmacogn Phytochem 2018,7(5),3417-3424","journal-title":"J Pharmacogn Phytochem"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.bionut.2012.08.008","volume":"2","author":"Murali R.","year":"2012","unstructured":"Murali R.; Saravanan R.; Antidiabetic effect of d-limonene, a monoterpene in streptozotocin-induced diabetic rats. Biomed Prevent Nutr 2012,2(4),269-275","journal-title":"Biomed Prevent Nutr"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1076\/phbi.40.7.512.14683","volume":"40","author":"Pari L.","year":"2002","unstructured":"Pari L.; Latha M.; Antidiabetic activity of Cassia auriculata flowers: Effect on lipid peroxidation in streptozotocin diabetes rats. Pharm Biol 2002,40(7),512-517","journal-title":"Pharm Biol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.phymed.2009.10.018","volume":"17","author":"Daisy P.","year":"2010","unstructured":"Daisy P.; Balasubramanian K.; Rajalakshmi M.; Eliza J.; Selvaraj J.; Insulin mimetic impact of Catechin isolated from Cassia fistula on the glucose oxidation and molecular mechanisms of glucose uptake on Streptozotocin-induced diabetic Wistar rats. Phytomedicine 2010,17(1),28-36","journal-title":"Phytomedicine"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jep.2013.08.043","volume":"150","author":"Yao X.","year":"2013","unstructured":"Yao X.; Chen F.; Li P.; Quan L.; Chen J.; Yu L.; Ding H.; Li C.; Chen L.; Gao Z.; Wan P.; Hu L.; Jiang H.; Shen X.; Natural product vindoline stimulates insulin secretion and efficiently ameliorates glucose homeostasis in diabetic murine models. J Ethnopharmacol 2013,150(1),285-297","journal-title":"J Ethnopharmacol"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s11684-014-0350-2","volume":"8","author":"Zhu X.","year":"2014","unstructured":"Zhu X.; Zeng X.; Sun C.; Chen S.; Biosynthetic pathway of terpenoid indole alkaloids in Catharanthus roseus. Front Med 2014,8(3),285-293","journal-title":"Front Med"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.phymed.2006.11.005","volume":"14","author":"Subash Babu P.","year":"2007","unstructured":"Subash Babu P.; Prabuseenivasan S.; Ignacimuthu S.; Cinnamaldehyde-A potential antidiabetic agent. Phytomedicine 2007,14(1),15-22","journal-title":"Phytomedicine"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3389\/fmicb.2011.00195","volume":"2","author":"Bevilacqua A.","year":"2011","unstructured":"Bevilacqua A.; Corbo M.R.; Sinigaglia M.; Use of essential oils to inhibit Alicyclobacillus acidoterrestris: A short overview of the literature. Front Microbiol 2011,2,195","journal-title":"Front Microbiol"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s40009-020-00911-5","volume":"44","author":"Bisht V.K.","year":"2021","unstructured":"Bisht V.K.; Cinnamomum tamala (Buch.-Ham.) T. Nees and Eberm.: An Alternative Source of Natural Linalool. Natl Acad Sci Lett 2021,44(1),59-61","journal-title":"Natl Acad Sci Lett"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1080\/10412905.2010.9700407","volume":"22","author":"Chanotiya C.S.","year":"2010","unstructured":"Chanotiya C.S.; Yadav A.; Enantioenriched (3S)-(+)-Linalool in the Leaf Oil of Cinnamomum tamala Nees et Eberm. from Kumaon. J Essent Oil Res 2010,22(6),593-596","journal-title":"J Essent Oil Res"},{"key":"ref=130","first-page":"159","volume":"6","author":"More T.","year":"2014","unstructured":"More T.; Kulkarni B.; Nalawade M.; Arvindekar A.; Antidiabetic Activity of Linalool and Limonene in Streptozotocin-Induced Diabetic Rat: A Combinatorial Therapy Approach. Int J Pharm Pharm Sci 2014,6,159-163","journal-title":"Int J Pharm Pharm Sci"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/ptr.1643","volume":"19","author":"Verspohl E.J.","year":"2005","unstructured":"Verspohl E.J.; Bauer K.; Neddermann E.; Antidiabetic effect of Cinnamomum cassia and Cinnamomum zeylanicum In vivo and In vitro. Phytother Res 2005,19(3),203-206","journal-title":"Phytother Res"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/1472-6882-13-275","volume":"13","author":"Ranasinghe P.","year":"2013","unstructured":"Ranasinghe P.; Pigera S.; Premakumara G.A.S.; Galappaththy P.; Constantine G.R.; Katulanda P.; Medicinal properties of \u2018true\u2019 cinnamon (Cinnamomum zeylanicum): A systematic review. BMC Complement Altern Med 2013,13(1),275","journal-title":"BMC Complement Altern Med"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"133","DOI":"10.13005\/bpj\/2107","volume":"14","author":"Koyagura N.","year":"2021","unstructured":"Koyagura N.; Kumar V.H.; Shanmugam C.; Anti-diabetic and hypolipidemic effect of Coccinia indica in glucocorticoid induced insulin resistance. Biomed Pharmacol J 2021,14(1),133-140","journal-title":"Biomed Pharmacol J"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.3390\/molecules23081839","volume":"23","author":"Fu M.","year":"2018","unstructured":"Fu M.; Wang L.; Wang X.; Deng B.; Hu X.; Zou J.; Determination of the five main terpenoids in different tissues of Wolfiporia cocos. Molecules 2018,23(8),1839","journal-title":"Molecules"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1001\/archinte.166.12.1311","volume":"166","author":"Pereira M.A.","year":"2006","unstructured":"Pereira M.A.; Parker E.D.; Folsom A.R.; Coffee consumption and risk of type 2 diabetes mellitus: an 11-year prospective study of 28 812 postmenopausal women. Arch Intern Med 2006,166(12),1311-1316","journal-title":"Arch Intern Med"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1007\/s00125-004-1590-5","volume":"47","author":"Yamaji T.","year":"2004","unstructured":"Yamaji T.; Mizoue T.; Tabata S.; Ogawa S.; Yamaguchi K.; Shimizu E.; Mineshita M.; Kono S.; Coffee consumption and glucose tolerance status in middle-aged Japanese men. Diabetologia 2004,47(12),2145-2151","journal-title":"Diabetologia"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1055\/s-2006-924982","volume":"38","author":"Bidel S.","year":"2006","unstructured":"Bidel S.; Hu G.; Sundvall J.; Kaprio J.; Tuomilehto J.; Effects of coffee consumption on glucose tolerance, serum glucose and insulin levels--a cross-sectional analysis. Horm Metab Res 2006,38(1),38-43","journal-title":"Horm Metab Res"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"112821","DOI":"10.1016\/j.fct.2022.112821","volume":"161","author":"Kusumah J.","year":"2022","unstructured":"Kusumah J.; Gonzalez de Mejia E.; Coffee constituents with antiadipogenic and antidiabetic potentials: A narrative review. Food Chem Toxicol 2022,161,112821","journal-title":"Food Chem Toxicol"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1615\/IntJMedMushrooms.2021040020","volume":"23","author":"Husen F.","year":"2021","unstructured":"Husen F.; Hernayanti H.; Ekowati N.; Sukmawati D.; Ratnaningtyas N.I.; Antidiabetic effects and antioxidant properties of the saggy ink cap medicinal mushroom, Coprinus comatus (Agaricomycetes), in Streptozotocin-induced hyperglycemic rats. Int J Med Mushrooms 2021,23(10),9-21","journal-title":"Int J Med Mushrooms"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.foodchem.2009.12.001","volume":"121","author":"Ding Z.","year":"2010","unstructured":"Ding Z.; Lu Y.; Lu Z.; Lv F.; Wang Y.; Bie X.; Wang F.; Zhang K.; Hypoglycaemic effect of comatin, an antidiabetic substance separated from Coprinus comatus broth, on alloxan-induced-diabetic rats. Food Chem 2010,121(1),39-43","journal-title":"Food Chem"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"112259","DOI":"10.1016\/j.fct.2021.112259","volume":"153","author":"Balahbib A.","year":"2021","unstructured":"Balahbib A.; El Omari N.; Hachlafi N.E.L.; Lakhdar F.; El Menyiy N.; Salhi N.; Mrabti H.N.; Bakrim S.; Zengin G.; Bouyahya A.; Health beneficial and pharmacological properties of p-cymene. Food Chem Toxicol 2021,153,112259","journal-title":"Food Chem Toxicol"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.apjtb.2015.04.001","volume":"5","author":"Mandal S.","year":"2015","unstructured":"Mandal S.; Mandal M.; Coriander (Coriandrum sativum L.) essential oil: Chemistry and biological activity. Asian Pac J Trop Biomed 2015,5(6),421-428","journal-title":"Asian Pac J Trop Biomed"},{"key":"ref=143","first-page":"193","volume":"8","author":"Chahal K.","year":"2018","unstructured":"Chahal K.; Singh R.; Kumar R.; Kumar A.; Bhardwaj U.; Chemical composition and biological activity of Coriandrum sativum L.: A Review. Indian J Nat Prod Resour 2018,8,193-203","journal-title":"Indian J Nat Prod Resour"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/B978-0-12-814466-4.00010-0","author":"Tung B.T.","year":"2019","unstructured":"Tung B.T.; Nham D.T.; Hai N.T.; Thu D.K.; Curcuma Longa, the Polyphenolic Curcumin Compound and Pharmacological Effects on Liver. Dietary Interventions in Liver Disease 2019,125-134","journal-title":"Dietary Interventions in Liver Disease"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.2174\/1568026615666150619142519","volume":"15","author":"Nabavi S.","year":"2015","unstructured":"Nabavi S.; Thiagarajan R.; Rastrelli L.; Daglia M.; Sobarzo-S&#xE1;nchez E.; Alinezhad H.; Nabavi S.; Curcumin: A natural product for diabetes and its complications. Curr Top Med Chem 2015,15(23),2445-2455","journal-title":"Curr Top Med Chem"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/nu12010118","volume":"12","author":"Den Hartogh D.J.","year":"2020","unstructured":"Den Hartogh D.J.; Gabriel A.; Tsiani E.; Antidiabetic Properties of Curcumin I: Evidence from in vitro Studies. Nutrients 2020,12(1),118","journal-title":"Nutrients"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1016\/j.fct.2010.06.032","volume":"48","author":"Lee S.H.","year":"2010","unstructured":"Lee S.H.; Park M.H.; Heo S.J.; Kang S.M.; Ko S.C.; Han J.S.; Jeon Y.J.; Dieckol isolated from Ecklonia cava inhibits &#x3B1;-glucosidase and &#x3B1;-amylase in vitro and alleviates postprandial hyperglycemia in streptozotocin-induced diabetic mice. Food Chem Toxicol 2010,48(10),2633-2637","journal-title":"Food Chem Toxicol"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1271\/bbb.120096","volume":"76","author":"Lee S.H.","year":"2012","unstructured":"Lee S.H.; Park M.H.; Kang S.M.; Ko S.C.; Kang M.C.; Cho S.; Park P.J.; Jeon B.T.; Kim S.K.; Han J.S.; Jeon Y.J.; Dieckol isolated from Ecklonia cava protects against high-glucose induced damage to rat insulinoma cells by reducing oxidative stress and apoptosis. Biosci Biotechnol Biochem 2012,76(8),1445-1451","journal-title":"Biosci Biotechnol Biochem"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1039\/c3fo60366k","volume":"5","author":"D\u2019souza J.J.","year":"2014","unstructured":"D\u2019souza J.J.; D\u2019souza P.P.; Fazal F.; Kumar A.; Bhat H.P.; Baliga M.S.; Anti-diabetic effects of the Indian indigenous fruit Emblica officinalis Gaertn: active constituents and modes of action. Food Funct 2014,5(4),635-644","journal-title":"Food Funct"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"152906","DOI":"10.1016\/j.phymed.2019.152906","volume":"73","author":"Variya B.C.","year":"2020","unstructured":"Variya B.C.; Bakrania A.K.; Patel S.S.; Antidiabetic potential of gallic acid from Emblica officinalis: Improved glucose transporters and insulin sensitivity through PPAR-&#x3B3; and Akt signaling. Phytomedicine 2020,73,152906","journal-title":"Phytomedicine"},{"key":"ref=151","first-page":"82","volume":"49","author":"Qu G-Z.","year":"2006","unstructured":"Qu G-Z.; Heo S-I.; Wang M-H.; Antioxidant and antidiabetic activities of Eucommia ulmoides Bark. J Appl Biol Chem 2006,49(3),82-85","journal-title":"J Appl Biol Chem"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jep.2004.03.047","volume":"93","author":"Kim H.Y.","year":"2004","unstructured":"Kim H.Y.; Moon B.H.; Lee H.J.; Choi D.H.; Flavonol glycosides from the leaves of Eucommia ulmoides O with glycation inhibitory activity. J Ethnopharmacol 2004,93(2-3),227-230","journal-title":"J Ethnopharmacol"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"1934578X1501000","DOI":"10.1177\/1934578X1501000140","volume":"10","author":"Chen J.","year":"2015","unstructured":"Chen J.; Mangelinckx S.; Adams A.; Wang Z.; Li W.; De Kimpe N.; Natural flavonoids as potential herbal medication for the treatment of diabetes mellitus and its complications. Nat Prod Commun 2015,10(1),1934578X1501000","journal-title":"Nat Prod Commun"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1002\/ptr.5411","volume":"29","author":"Jeong S.Y.","year":"2015","unstructured":"Jeong S.Y.; Nguyen P.H.; Zhao B.T.; Ali M.Y.; Choi J.S.; Min B.S.; Woo M.H.; Chemical constituents of Euonymus alatus (Thunb.) Sieb. and their PTP1B and &#x3B1;-glucosidase inhibitory activities. Phytother Res 2015,29(10),1540-1548","journal-title":"Phytother Res"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/9425714","volume":"2016","author":"Zhai X.","year":"2016","unstructured":"Zhai X.; Lenon G.B.; Xue C.C.L.; Li C.G.; Euonymus alatus: A review on its phytochemistry and antidiabetic activity. Evid Based Complement Alternat Med 2016,2016,1-12","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=156","first-page":"50","volume":"17","author":"Chandramohan G.","year":"2015","unstructured":"Chandramohan G.; Al-Numair K.S.; Alsaif M.A.; Veeramani C.; Antidiabetic effect of kaempferol a flavonoid compound, on streptozotocin-induced diabetic rats with special reference to glycoprotein components. Prog Nutr 2015,17(1),50-57","journal-title":"Prog Nutr"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3390\/biom9090430","volume":"9","author":"AL-Ishaq R.K.","year":"2019","unstructured":"AL-Ishaq R.K.; Abotaleb M.; Kubatka P.; Kajo K.; B&#xFC;sselberg D.; Flavonoids and their anti-diabetic effects: Cellular mechanisms and effects to improve blood sugar levels. Biomolecules 2019,9(9),430","journal-title":"Biomolecules"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.etap.2016.02.010","volume":"43","author":"Samadder A.","year":"2016","unstructured":"Samadder A.; Abraham S.K.; Khuda-Bukhsh A.R.; Nanopharmaceutical approach using pelargonidin towards enhancement of efficacy for prevention of alloxan-induced DNA damage in L6 cells via activation of PARP and p53. Environ Toxicol Pharmacol 2016,43,27-37","journal-title":"Environ Toxicol Pharmacol"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1055\/s-0043-100017","volume":"83","author":"Samadder A.","year":"2017","unstructured":"Samadder A.; Tarafdar D.; Abraham S.; Ghosh K.; Khuda-Bukhsh A.; Nano-Pelargonidin protects hyperglycemic-induced l6 cells against mitochondrial dysfunction. Planta Med 2017,83(5),468-475","journal-title":"Planta Med"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.3390\/molecules27103286","volume":"27","author":"Bouyahya A.","year":"2022","unstructured":"Bouyahya A.; Omari N.E.; E.L. Hachlafi N.; Jemly M.E.; Hakkour M.; Balahbib A.; El Menyiy N.; Bakrim S.; Naceiri Mrabti H.; Khouchlaa A.; Mahomoodally M.F.; Catauro M.; Montesano D.; Zengin G.; Chemical compounds of berry-derived polyphenols and their effects on gut microbiota, inflammation, and cancer. Molecules 2022,27(10),3286","journal-title":"Molecules"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.phymed.2010.03.019","volume":"17","author":"Ahmed A.B.A.","year":"2010","unstructured":"Ahmed A.B.A.; Rao A.S.; Rao M.V.; In vitro callus and in vivo leaf extract of Gymnema sylvestre stimulate &#x3B2;-cells regeneration and anti-diabetic activity in Wistar rats. Phytomedicine 2010,17(13),1033-1039","journal-title":"Phytomedicine"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/10286020008041372","volume":"2","author":"Sugihara Y.","year":"2000","unstructured":"Sugihara Y.; Nojima H.; Matsuda H.; Murakami T.; Yoshikawa M.; Kimura I.; Antihyperglycemic effects of gymnemic acid IV, a compound derived from Gymnema sylvestre leaves in streptozotocin-diabetic mice. J Asian Nat Prod Res 2000,2(4),321-327","journal-title":"J Asian Nat Prod Res"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jff.2014.11.001","volume":"12","author":"Kaewseejan N.","year":"2015","unstructured":"Kaewseejan N.; Sutthikhum V.; Siriamornpun S.; Potential of Gynura procumbens leaves as source of flavonoid-enriched fractions with enhanced antioxidant capacity. J Funct Foods 2015,12,120-128","journal-title":"J Funct Foods"},{"key":"ref=164","first-page":"238","volume":"17","author":"Chandramohan G.","year":"2015","unstructured":"Chandramohan G.; Al-Numair K.S.; Veeramani C.; Alsaif M.A.; Almajwal A.M.; Protective effect of kaempferol, a flavonoid compound, on oxidative mitochondrial damage in streptozotocin-induced diabetic rats. Prog Nutr 2015,17(3),238-244","journal-title":"Prog Nutr"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jep.2005.12.020","volume":"106","author":"Ajikumaran Nair S.","year":"2006","unstructured":"Ajikumaran Nair S.; Shylesh B.S.; Gopakumar B.; Subramoniam A.; Anti-diabetes and hypoglycaemic properties of Hemionitis arifolia (Burm.) Moore in rats. J Ethnopharmacol 2006,106(2),192-197","journal-title":"J Ethnopharmacol"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"11795514211042023","DOI":"10.1177\/11795514211042023","volume":"14","author":"Ran\u0111elovi\u0107 S.","year":"2021","unstructured":"Ran\u0111elovi\u0107 S.; Bipat R.; A review of coumarins and coumarin-related compounds for their potential antidiabetic effect. Clin Med Insights Endocrinol Diabetes 2021,14,11795514211042023","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1111\/jphp.12774","volume":"69","author":"Li H.","year":"2017","unstructured":"Li H.; Yao Y.; Li L.; Coumarins as potential antidiabetic agents. J Pharm Pharmacol 2017,69(10),1253-1264","journal-title":"J Pharm Pharmacol"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.fitote.2008.04.002","volume":"79","author":"Cunha W.R.","year":"2008","unstructured":"Cunha W.R.; Arantes G.M.; Ferreira D.S.; Lucarini R.; Silva M.L.A.; Furtado N.A.J.C.; da Silva Filho A.A.; Crotti A.E.M.; Ara&#xFA;jo A.R.B.; Hypoglicemic effect of Leandra lacunosa in normal and alloxan-induced diabetic rats. Fitoterapia 2008,79(5),356-360","journal-title":"Fitoterapia"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3390\/medicina55070353","volume":"55","author":"Saleem M.","year":"2019","unstructured":"Saleem M.; Tanvir M.; Akhtar M.F.; Iqbal M.; Saleem A.; Antidiabetic Potential of Mangifera indica L. cv. Anwar ratol leaves: medicinal application of food wastes. Medicina (Kaunas) 2019,55(7),353","journal-title":"Medicina (Kaunas)"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1208\/s12249-014-0206-8","volume":"16","author":"Kammalla A.K.","year":"2015","unstructured":"Kammalla A.K.; Ramasamy M.K.; Inampudi J.; Dubey G.P.; Agrawal A.; Kaliappan I.; Comparative pharmacokinetic study of mangiferin after oral administration of pure mangiferin and US patented polyherbal formulation to rats. AAPS PharmSciTech 2015,16(2),250-258","journal-title":"AAPS PharmSciTech"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"61","DOI":"10.7897\/2230-8407.100111","volume":"10","author":"Ahamad J.","year":"2019","unstructured":"Ahamad J.; Mir S.R.; Amin S.; Antihyperglycemic activity of charantin isolated from fruits of Momordica charantia Linn. Int Res J Pharm 2019,10(1),61-64","journal-title":"Int Res J Pharm"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S2222-1808(13)60052-3","volume":"3","author":"Joseph B.","year":"2013","unstructured":"Joseph B.; Jini D.; Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency. Asian Pac J Trop Dis 2013,3(2),93-102","journal-title":"Asian Pac J Trop Dis"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/9680508","volume":"2020","author":"Yan Y.","year":"2020","unstructured":"Yan Y.; Zhou X.; Guo K.; Zhou F.; Yang H.; Use of chlorogenic acid against diabetes mellitus and its complications. J Immunol Res 2020,2020,1-6","journal-title":"J Immunol Res"},{"key":"ref=174","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120842","volume":"10","author":"Jin S.","year":"2015","unstructured":"Jin S.; Chang C.; Zhang L.; Liu Y.; Huang X.; Chen Z.; Chlorogenic acid improves late diabetes through adiponectin receptor signaling pathways in db\/db mice. PLoS One 2015,10(4)","journal-title":"PLoS One"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/9276343","volume":"2020","author":"Abdel Aziz S.M.","year":"2020","unstructured":"Abdel Aziz S.M.; Ahmed O.M.; Abd EL-Twab, S.M.; Al-Muzafar, H.M.; Amin, K.A.; Abdel-Gabbar, M. Antihyperglycemic effects and mode of actions of Musa paradisiaca leaf and fruit peel hydroethanolic extracts in nicotinamide\/streptozotocin-induced diabetic rats. Evid Based Complement Alternat Med 2020,2020,1-15","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1080\/15376516.2018.1545815","volume":"29","author":"Ponnulakshmi R.","year":"2019","unstructured":"Ponnulakshmi R.; Shyamaladevi B.; Vijayalakshmi P.; Selvaraj J.; In silico and in vivo analysis to identify the antidiabetic activity of beta sitosterol in adipose tissue of high fat diet and sucrose induced type-2 diabetic experimental rats. Toxicol Mech Methods 2019,29(4),276-290","journal-title":"Toxicol Mech Methods"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1749-8546-8-11","volume":"8","author":"Hashim M.","year":"2013","unstructured":"Hashim M.; Yam M.F.; Hor S.Y.; Lim C.P.; Asmawi M.; Sadikun A.; Anti-hyperglycaemic activity of Swietenia macrophylla king (meliaceae) seed extracts in normoglycaemic rats undergoing glucose tolerance tests. Chin Med 2013,8(1),11","journal-title":"Chin Med"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4021\/jem12e","volume":"1","author":"Mathur M.L.","year":"2011","unstructured":"Mathur M.L.; Antidiabetic properties of a spice plant Nigella sativa. J Endocrinol Metab 2011,1(1),1-8","journal-title":"J Endocrinol Metab"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s13410-012-0067-1","volume":"32","author":"AbuKhader M.M.","year":"2012","unstructured":"AbuKhader M.M.; Thymoquinone: A promising antidiabetic agent. Int J Diabetes Dev Ctries 2012,32(2),65-68","journal-title":"Int J Diabetes Dev Ctries"},{"key":"ref=180","first-page":"125","volume":"49","author":"Prakash P.","year":"2005","unstructured":"Prakash P.; Gupta N.; Therapeutic uses of Ocimum sanctum Linn (Tulsi) with a note on eugenol and its pharmacological actions: A short review. Indian J Physiol Pharmacol 2005,49(2),125-131","journal-title":"Indian J Physiol Pharmacol"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"18798","DOI":"10.1038\/srep18798","volume":"6","author":"Singh P.","year":"2016","unstructured":"Singh P.; Jayaramaiah R.H.; Agawane S.B.; Vannuruswamy G.; Korwar A.M.; Anand A.; Dhaygude V.S.; Shaikh M.L.; Joshi R.S.; Boppana R.; Kulkarni M.J.; Thulasiram H.V.; Giri A.P.; Potential dual role of eugenol in inhibiting advanced glycation end products in diabetes: Proteomic and mechanistic insights. Sci Rep 2016,6(1),18798","journal-title":"Sci Rep"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"54","DOI":"10.32474\/ADO.2018.01.000113","volume":"1","author":"Annunziata G.","year":"2018","unstructured":"Annunziata G.; Oleuropein as a novel anti-diabetic nutraceutical. An overview. Arch Diabetes Obesity 2018,1(3),54-58","journal-title":"Arch Diabetes Obesity"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"246","DOI":"10.4236\/ajac.2015.63023","volume":"6","author":"Afaneh I.","year":"2015","unstructured":"Afaneh I.; Yateem H.; Al-Rimawi F.; Effect of olive leaves drying on the content of oleuropein. Am J Anal Chem 2015,6(3),246-252","journal-title":"Am J Anal Chem"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3839\/jabc.2018.037","volume":"61","author":"Kwon H.W.","year":"2018","unstructured":"Kwon H.W.; 20(S)-ginsenoside Rg3 inhibits glycoprotein IIb\/IIIa activation in human platelets. J Appl Biol Chem 2018,61(3),257-265","journal-title":"J Appl Biol Chem"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.2337\/diabetes.51.6.1851","volume":"51","author":"Attele A.S.","year":"2002","unstructured":"Attele A.S.; Zhou Y.P.; Xie J.T.; Wu J.A.; Zhang L.; Dey L.; Pugh W.; Rue P.A.; Polonsky K.S.; Yuan C.S.; Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 2002,51(6),1851-1858","journal-title":"Diabetes"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1556\/AChrom.25.2013.1.10","volume":"25","author":"Bhope S.G.","year":"2013","unstructured":"Bhope S.G.; Kuber V.V.; Nagore D.H.; Gaikwad P.S.; Patil M.J.; Development and validation of RP-HPLC method for simultaneous analysis of andrographolide, phyllanthin, and hypophyllanthin from herbal hepatoprotective formulation. Acta Chromatogr 2013,25(1),159-169","journal-title":"Acta Chromatogr"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3389\/fphar.2019.00878","volume":"10","author":"Jantan I.","year":"2019","unstructured":"Jantan I.; Haque M.A.; Ilangkovan M.; Arshad L.; An insight into the modulatory effects and mechanisms of action of phyllanthus species and their bioactive metabolites on the immune system. Front Pharmacol 2019,10,878","journal-title":"Front Pharmacol"},{"key":"ref=188","first-page":"358","volume":"18","author":"Gharib E.","year":"2019","unstructured":"Gharib E.; Montasser Kouhsari S.; Study of the antidiabetic activity of Punica granatum L. fruits aqueous extract on the alloxan-diabetic wistar rats. Iran J Pharm Res 2019,18(1),358-368","journal-title":"Iran J Pharm Res"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.nutres.2013.03.003","volume":"33","author":"Banihani S.","year":"2013","unstructured":"Banihani S.; Swedan S.; Alguraan Z.; Pomegranate and type 2 diabetes. Nutr Res 2013,33(5),341-348","journal-title":"Nutr Res"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.foodchem.2009.04.123","volume":"118","author":"Lee C.J.","year":"2010","unstructured":"Lee C.J.; Chen L.G.; Liang W.L.; Wang C.C.; Anti-inflammatory effects of Punica granatum Linne in vitro and in vivo. Food Chem 2010,118(2),315-322","journal-title":"Food Chem"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.sajb.2019.05.030","volume":"124","author":"Kshirsagar P.R.","year":"2019","unstructured":"Kshirsagar P.R.; Jagtap U.B.; Gaikwad N.B.; Bapat V.A.; Ethanopharmacology, phytochemistry and pharmacology of medicinally potent genus Swertia: An update. S Afr J Bot 2019,124,444-483","journal-title":"S Afr J Bot"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.phymed.2009.10.007","volume":"17","author":"Tian L.Y.","year":"2010","unstructured":"Tian L.Y.; Bai X.; Chen X.H.; Fang J.B.; Liu S.H.; Chen J.C.; Anti-diabetic effect of methylswertianin and bellidifolin from Swertia punicea Hemsl. and its potential mechanism. Phytomedicine 2010,17(7),533-539","journal-title":"Phytomedicine"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.jams.2012.09.001","volume":"5","author":"Samadder A.","year":"2012","unstructured":"Samadder A.; Das S.; Das J.; Paul A.; Khuda-Bukhsh A.R.; Ameliorative effects of Syzygium jambolanum extract and its poly (lactic-co-glycolic) acid nano-encapsulated form on arsenic-induced hyperglycemic stress: A multi-parametric evaluation. J Acupunct Meridian Stud 2012,5(6),310-318","journal-title":"J Acupunct Meridian Stud"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ejps.2011.07.012","volume":"44","author":"Samadder A.","year":"2011","unstructured":"Samadder A.; Chakraborty D.; De A.; Bhattacharyya S.S.; Bhadra K.; Khuda-Bukhsh A.R.; Possible signaling cascades involved in attenuation of alloxan-induced oxidative stress and hyperglycemia in mice by ethanolic extract of Syzygium jambolanum: Drug-DNA interaction with calf thymus DNA as target. Eur J Pharm Sci 2011,44(3),207-217","journal-title":"Eur J Pharm Sci"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.phymed.2018.09.195","volume":"57","author":"Mohanty I.R.","year":"2019","unstructured":"Mohanty I.R.; Borde M.; Kumar C.; S.; Maheshwari, U. Dipeptidyl peptidase IV Inhibitory activity of Terminalia arjuna attributes to its cardioprotective effects in experimental diabetes: In silico, in vitro and in vivo analyses. Phytomedicine 2019,57,158-165","journal-title":"Phytomedicine"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/BF02912926","volume":"21","author":"Ragavan B.","year":"2006","unstructured":"Ragavan B.; Krishnakumari S.; Antidiabetic effect ofT. arjuna bark extract in alloxan induced diabetic rats. Indian J Clin Biochem 2006,21(2),123-128","journal-title":"Indian J Clin Biochem"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.toxrep.2015.02.008","volume":"2","author":"Varghese A.","year":"2015","unstructured":"Varghese A.; Savai J.; Pandita N.; Gaud R.; In vitro modulatory effects of Terminalia arjuna, arjunic acid, arjunetin and arjungenin on CYP3A4, CYP2D6 and CYP2C9 enzyme activity in human liver microsomes. Toxicol Rep 2015,2,806-816","journal-title":"Toxicol Rep"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0378-8741(03)00208-3","volume":"88","author":"Nagappa A.N.","year":"2003","unstructured":"Nagappa A.N.; Thakurdesai P.A.; Venkat Rao N.; Singh J.; Antidiabetic activity of Terminalia catappa Linn fruits. J Ethnopharmacol 2003,88(1),45-50","journal-title":"J Ethnopharmacol"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/jphp.12676","volume":"69","author":"Behl T.","year":"2017","unstructured":"Behl T.; Kotwani A.; Proposed mechanisms of Terminalia catappa in hyperglycaemia and associated diabetic complications. J Pharm Pharmacol 2017,69(2),123-134","journal-title":"J Pharm Pharmacol"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S2221-1691(15)30173-8","volume":"5","author":"Sharma R.","year":"2015","unstructured":"Sharma R.; Amin H.; Galib.; Prajapati, P.K. Antidiabetic claims of Tinospora cordifolia (Willd.) Miers: Critical appraisal and role in therapy. Asian Pac J Trop Biomed 2015,5(1),68-78","journal-title":"Asian Pac J Trop Biomed"},{"key":"ref=201","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0378-8741(89)90087-1","volume":"27","author":"Noor H.","year":"1989","unstructured":"Noor H.; Ashcroft S.J.H.; Antidiabetic effects of Tinospora crispa in rats. J Ethnopharmacol 1989,27(1-2),149-161","journal-title":"J Ethnopharmacol"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"67","DOI":"10.17756\/jfcn.2017-039","volume":"3","author":"Baliga M.S.","year":"2017","unstructured":"Baliga M.S.; Palatty P.L.; Adnan M.; Naik T.S.; Kamble P.S.; George T.; D\u2019souza J.J.; Anti-Diabetic effects of leaves of Trigonella foenum-graecum L. (Fenugreek): Leads from preclinical studies. J Food Chem Nanotechnol 2017,3(2),67-71","journal-title":"J Food Chem Nanotechnol"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"27961","DOI":"10.1039\/D0RA05126H","volume":"10","author":"Shawky E.","year":"2020","unstructured":"Shawky E.; Nada A.A.; Ibrahim R.S.; Potential role of medicinal plants and their constituents in the mitigation of SARS-CoV-2: Identifying related therapeutic targets using network pharmacology and molecular docking analyses. RSC Advances 2020,10(47),27961-27983","journal-title":"RSC Advances"},{"key":"ref=204","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/s12906-017-1903-0","volume":"17","author":"Samad M.B.","year":"2017","unstructured":"Samad M.B.; Mohsin M.N.A.B.; Razu B.A.; Hossain M.T.; Mahzabeen S.; Unnoor N.; Muna I.A.; Akhter F.; Kabir A.U.; Hannan J.M.A.; [6]-Gingerol, from Zingiber officinale, potentiates GLP-1 mediated glucose-stimulated insulin secretion pathway in pancreatic &#x3B2;-cells and increases RAB8\/RAB10-regulated membrane presentation of GLUT4 transporters in skeletal muscle to improve hyperglycemia in Leprdb\/db type 2 diabetic mice. BMC Complement Altern Med 2017,17(1),395","journal-title":"BMC Complement Altern Med"},{"key":"ref=205","doi-asserted-by":"publisher","first-page":"516870","DOI":"10.1155\/2012\/516870","volume":"2012","author":"Li Y.","year":"2012","unstructured":"Li Y.; Tran V.H.; Duke C.C.; Roufogalis B.D.; Preventive and Protective Properties of Zingiber officinale (Ginger) in diabetes mellitus, diabetic complications, and associated lipid and other metabolic disorders: A brief review. Evid Based Complement Alternat Med 2012,2012,516870","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=206","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.phytochem.2015.07.012","volume":"117","author":"Semwal R.B.","year":"2015","unstructured":"Semwal R.B.; Semwal D.K.; Combrinck S.; Viljoen A.M.; Gingerols and shogaols: Important nutraceutical principles from ginger. Phytochemistry 2015,117,554-568","journal-title":"Phytochemistry"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"66","DOI":"10.22270\/ajprd.v7i1.469","volume":"7","author":"Maqbool M.","year":"2019","unstructured":"Maqbool M.; Gani I.; Dar M.A.; Anti-Diabetic effects of some medicinal plants in experimental animals: A review. Asian J Pharmaceut Res Develop 2019,7(1),66-69","journal-title":"Asian J Pharmaceut Res Develop"},{"key":"ref=208","doi-asserted-by":"publisher","first-page":"555868","DOI":"10.19080\/CRDOJ.2020.13.555868","volume":"13","author":"Kumar S.","year":"2020","unstructured":"Kumar S.; Diabetes Mellitus and allopathic medication increase the risk of cancer malignancy, but no side effect associated with the use of antidiabetic herbal medicine. Curr Res Diabetes Obes J 2020,13(4),555868","journal-title":"Curr Res Diabetes Obes J"},{"key":"ref=209","first-page":"36","volume":"3","author":"Modak D.A.","year":"2015","unstructured":"Modak D.A.; Review: Anti-diabetic activity of herbal drugs. PharmaTutor 2015,3(9),36-42","journal-title":"PharmaTutor"},{"key":"ref=210","first-page":"86","volume":"2","author":"Bordoloi R.","year":"2014","unstructured":"Bordoloi R.; Dutta K.N.; A review on herbs used in the treatment of Diabetes Mellitus. J Pharm Chem Bio Sci 2014,2(2),86-92","journal-title":"J Pharm Chem Bio Sci"},{"key":"ref=211","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5138\/09750185.2181","volume":"10","author":"Verma S.","year":"2018","unstructured":"Verma S.; Gupta M.; Popli H.; Aggarwal G.; Diabetes Mellitus treatment using herbal drugs. Int J Phytomedicine 2018,10(1),1","journal-title":"Int J Phytomedicine"},{"key":"ref=212","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.31142\/ijtsrd12884","volume":"2","author":"Gadhiya J.","year":"2018","unstructured":"Gadhiya J.; Jaithliya T.; Somani S.S.M.N.; Herbals and its marketed formulations to treat Diabetes Mellitus DM: An overview. Int J Trend Sci Res Develop 2018,2(-3),2602-2613","journal-title":"Int J Trend Sci Res Develop"},{"key":"ref=213","first-page":"343","volume":"1","author":"Khan M.Y.","year":"2014","unstructured":"Khan M.Y.; Aziz I.; Bihari B.; Kumar H.; Roy M.; Verma V.K.A.; Review-phytomedicines used in treatment of Diabetes. Int J Pharmacogn 2014,1(6),343-365","journal-title":"Int J Pharmacogn"},{"key":"ref=214","first-page":"24","volume":"1","author":"Venu G.J.","year":"2013","unstructured":"Venu G.J.; Nilakash S.; Antidiabetic herbal products marketed in India: An update. J Med Plants Stud 2013,1(6),24-26","journal-title":"J Med Plants Stud"},{"key":"ref=215","first-page":"1200","volume":"2","author":"Rajesham V.V.","year":"2012","unstructured":"Rajesham V.V.; Ravindernath A.; Bikshapathi D.V.R.N.; A review on medicinal plant and herbal drug formulation used in Diabetes Mellitus. Indo Am J Pharmaceut Res 2012,2(10),1200-1212","journal-title":"Indo Am J Pharmaceut Res"},{"key":"ref=216","doi-asserted-by":"publisher","first-page":"17","DOI":"10.7897\/2230-8407.08690","volume":"8","author":"Rani A.","year":"2017","unstructured":"Rani A.; Arora S.; Goyal A.; Antidiabetic plants in traditional medicines: A review. Int Res J Pharm 2017,8(6),17-24","journal-title":"Int Res J Pharm"},{"key":"ref=217","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002533","volume":"14","author":"Sender R.","year":"2016","unstructured":"Sender R.; Fuchs S.; Milo R.; Revised estimates for the number of human and bacteria cells in the body. PLoS Biol 2016,14(8)","journal-title":"PLoS Biol"},{"key":"ref=218","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.chom.2008.02.015","volume":"3","author":"Turnbaugh P.J.","year":"2008","unstructured":"Turnbaugh P.J.; B&#xE4;ckhed F.; Fulton L.; Gordon J.I.; Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 2008,3(4),213-223","journal-title":"Cell Host Microbe"},{"key":"ref=219","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3920\/BM2012.0029","volume":"4","author":"Rothe M.","year":"2013","unstructured":"Rothe M.; Blaut M.; Evolution of the gut microbiota and the influence of diet. Benef Microbes 2013,4(1),31-37","journal-title":"Benef Microbes"},{"key":"ref=220","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109434","volume":"9","author":"Kong L.C.","year":"2014","unstructured":"Kong L.C.; Holmes B.A.; Cotillard A.; Habi-Rachedi F.; Brazeilles R.; Gougis S.; Gausser&#xE8;s N.; Cani P.D.; Fellahi S.; Bastard J.P.; Kennedy S.P.; Dor&#xE9; J.; Ehrlich S.D.; Zucker J.D.; Rizkalla S.W.; Cl&#xE9;ment K.; Dietary patterns differently associate with inflammation and gut microbiota in overweight and obese subjects. PLoS One 2014,9(10)","journal-title":"PLoS One"},{"key":"ref=221","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1126\/science.1208344","volume":"334","author":"Wu G.D.","year":"2011","unstructured":"Wu G.D.; Chen J.; Hoffmann C.; Bittinger K.; Chen Y.Y.; Keilbaugh S.A.; Bewtra M.; Knights D.; Walters W.A.; Knight R.; Sinha R.; Gilroy E.; Gupta K.; Baldassano R.; Nessel L.; Li H.; Bushman F.D.; Lewis J.D.; Linking long-term dietary patterns with gut microbial enterotypes. Science 2011,334(6052),105-108","journal-title":"Science"},{"key":"ref=222","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1126\/science.1198719","volume":"332","author":"Muegge B.D.","year":"2011","unstructured":"Muegge B.D.; Kuczynski J.; Knights D.; Clemente J.C.; Gonz&#xE1;lez A.; Fontana L.; Henrissat B.; Knight R.; Gordon J.I.; Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science 2011,332(6032),970-974","journal-title":"Science"},{"key":"ref=223","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/oby.2011.36","volume":"19","author":"G&#xF3;mez-Ambrosi J.","year":"2011","unstructured":"G&#xF3;mez-Ambrosi J.; Silva C.; Galofr&#xE9; J.C.; Escalada J.; Santos S.; Gil M.J.; Valent&#xED; V.; Rotellar F.; Ram&#xED;rez B.; Salvador J.; Fr&#xFC;hbeck G.; Body adiposity and type 2 diabetes: increased risk with a high body fat percentage even having a normal BMI. Obesity (Silver Spring) 2011,19(7),1439-1444","journal-title":"Obesity (Silver Spring)"},{"key":"ref=224","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/oby.22088","volume":"26","author":"Gao R.","year":"2018","unstructured":"Gao R.; Zhu C.; Li H.; Yin M.; Pan C.; Huang L.; Kong C.; Wang X.; Zhang Y.; Qu S.; Qin H.; Dysbiosis signatures of gut microbiota along the sequence from healthy, young patients to those with overweight and obesity. Obesity (Silver Spring) 2018,26(2),351-361","journal-title":"Obesity (Silver Spring)"},{"key":"ref=225","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/nm.4345","volume":"23","author":"Wu H.","year":"2017","unstructured":"Wu H.; Esteve E.; Tremaroli V.; Khan M.T.; Caesar R.; Manner&#xE5;s-Holm L.; St&#xE5;hlman M.; Olsson L.M.; Serino M.; Planas-F&#xE8;lix M.; Xifra G.; Mercader J.M.; Torrents D.; Burcelin R.; Ricart W.; Perkins R.; Fern&#xE0;ndez-Real J.M.; B&#xE4;ckhed F.; Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat Med 2017,23(7),850-858","journal-title":"Nat Med"},{"key":"ref=226","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2220\/biomedres.36.63","volume":"36","author":"Le T.K.C.","year":"2015","unstructured":"Le T.K.C.; Hosaka T.; Nguyen T.T.; Kassu A.; Dang T.O.; Tran H.B.; Pham T.P.; Tran Q.B.; Le T.H.H.; Pham X.D.; Bifidobacterium species lower serum glucose, increase expressions of insulin signaling proteins, and improve adipokine profile in diabetic mice. Biomed Res 2015,36(1),63-70","journal-title":"Biomed Res"},{"key":"ref=227","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","volume":"24","author":"Sun L.","year":"2018","unstructured":"Sun L.; Xie C.; Wang G.; Wu Y.; Wu Q.; Wang X.; Liu J.; Deng Y.; Xia J.; Chen B.; Zhang S.; Yun C.; Lian G.; Zhang X.; Zhang H.; Bisson W.H.; Shi J.; Gao X.; Ge P.; Liu C.; Krausz K.W.; Nichols R.G.; Cai J.; Rimal B.; Patterson A.D.; Wang X.; Gonzalez F.J.; Jiang C.; Gut microbiota and intestinal FXR mediate the clinical benefits of metformin. Nat Med 2018,24(12),1919-1929","journal-title":"Nat Med"},{"key":"ref=228","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041079","volume":"7","author":"Gauffin Cano P.","year":"2012","unstructured":"Gauffin Cano P.; Santacruz A.; Moya &#xC1;.; Sanz Y.; Bacteroides uniformis CECT 7771 ameliorates metabolic and immunological dysfunction in mice with high-fat-diet induced obesity. PLoS One 2012,7(7)","journal-title":"PLoS One"},{"key":"ref=229","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature12198","volume":"498","author":"Karlsson F.H.","year":"2013","unstructured":"Karlsson F.H.; Tremaroli V.; Nookaew I.; Bergstr&#xF6;m G.; Behre C.J.; Fagerberg B.; Nielsen J.; B&#xE4;ckhed F.; Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 2013,498(7452),99-103","journal-title":"Nature"},{"key":"ref=230","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1038\/ismej.2017.24","volume":"11","author":"Munukka E.","year":"2017","unstructured":"Munukka E.; Rintala A.; Toivonen R.; Nylund M.; Yang B.; Takanen A.; H&#xE4;nninen A.; Vuopio J.; Huovinen P.; Jalkanen S.; Pekkala S.; Faecalibacterium prausnitzii treatment improves hepatic health and reduces adipose tissue inflammation in high-fat fed mice. ISME J 2017,11(7),1667-1679","journal-title":"ISME J"},{"key":"ref=231","doi-asserted-by":"publisher","first-page":"13329","DOI":"10.1038\/ncomms13329","volume":"7","author":"Greer R.L.","year":"2016","unstructured":"Greer R.L.; Dong X.; Moraes A.C.F.; Zielke R.A.; Fernandes G.R.; Peremyslova E.; Vasquez-Perez S.; Schoenborn A.A.; Gomes E.P.; Pereira A.C.; Ferreira S.R.G.; Yao M.; Fuss I.J.; Strober W.; Sikora A.E.; Taylor G.A.; Gulati A.S.; Morgun A.; Shulzhenko N.; Akkermansia muciniphila mediates negative effects of IFN&#x3B3; on glucose metabolism. Nat Commun 2016,7(1),13329","journal-title":"Nat Commun"},{"key":"ref=232","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1021\/acs.jproteome.8b00282","volume":"17","author":"Martinic A.","year":"2018","unstructured":"Martinic A.; Barouei J.; Bendiks Z.; Mishchuk D.; Heeney D.D.; Martin R.; Marco M.L.; Slupsky C.M.; Supplementation of Lactobacillus plantarum improves markers of metabolic dysfunction induced by a high fat diet. J Proteome Res 2018,17(8),2790-2802","journal-title":"J Proteome Res"},{"key":"ref=233","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s11695-016-2399-2","volume":"27","author":"Murphy R.","year":"2017","unstructured":"Murphy R.; Tsai P.; J&#xFC;llig M.; Liu A.; Plank L.; Booth M.; Differential changes in gut microbiota after gastric bypass and sleeve gastrectomy bariatric surgery vary according to diabetes remission. Obes Surg 2017,27(4),917-925","journal-title":"Obes Surg"},{"key":"ref=234","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071108","volume":"8","author":"Zhang X.","year":"2013","unstructured":"Zhang X.; Shen D.; Fang Z.; Jie Z.; Qiu X.; Zhang C.; Chen Y.; Ji L.; Human gut microbiota changes reveal the progression of glucose intolerance. PLoS One 2013,8(8)","journal-title":"PLoS One"},{"key":"ref=235","doi-asserted-by":"publisher","first-page":"460","DOI":"10.5455\/medarh.2013.67.460-463","volume":"67","author":"Kulas T.","year":"2013","unstructured":"Kulas T.; Bursac D.; Zegarac Z.; PlaninicRados, G.; Hrgovic, Z. New views on cesarean section, its possible complications and long-term consequences for children\u2019s health. Med Arh 2013,67(6),460-463","journal-title":"Med Arh"},{"key":"ref=236","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/obr.12267","volume":"16","author":"Kuhle S.","year":"2015","unstructured":"Kuhle S.; Tong O.S.; Woolcott C.G.; Association between caesarean section and childhood obesity: A systematic review and meta-analysis. Obes Rev 2015,16(4),295-303","journal-title":"Obes Rev"},{"key":"ref=237","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3945\/ajcn.112.037382","volume":"96","author":"Cabrera-Rubio R.","year":"2012","unstructured":"Cabrera-Rubio R.; Collado M.C.; Laitinen K.; Salminen S.; Isolauri E.; Mira A.; The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. Am J Clin Nutr 2012,96(3),544-551","journal-title":"Am J Clin Nutr"},{"key":"ref=238","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1177\/0884533616670150","volume":"32","author":"Fitzstevens J.L.","year":"2017","unstructured":"Fitzstevens J.L.; Smith K.C.; Hagadorn J.I.; Caimano M.J.; Matson A.P.; Brownell E.A.; Systematic review of the human milk microbiota. Nutr Clin Pract 2017,32(3),354-364","journal-title":"Nutr Clin Pract"},{"key":"ref=239","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/jp.2015.199","volume":"36","author":"Panagos P.G.","year":"2016","unstructured":"Panagos P.G.; Vishwanathan R.; Penfield-Cyr A.; Matthan N.R.; Shivappa N.; Wirth M.D.; Hebert J.R.; Sen S.; Breastmilk from obese mothers has pro-inflammatory properties and decreased neuroprotective factors. J Perinatol 2016,36(4),284-290","journal-title":"J Perinatol"},{"key":"ref=240","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.cell.2014.09.053","volume":"159","author":"Goodrich J.K.","year":"2014","unstructured":"Goodrich J.K.; Waters J.L.; Poole A.C.; Sutter J.L.; Koren O.; Blekhman R.; Beaumont M.; Van Treuren W.; Knight R.; Bell J.T.; Spector T.D.; Clark A.G.; Ley R.E.; Human genetics shape the gut microbiome. Cell 2014,159(4),789-799","journal-title":"Cell"},{"key":"ref=241","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1136\/gut.2010.216259","volume":"60","author":"Rehman A.","year":"2011","unstructured":"Rehman A.; Sina C.; Gavrilova O.; H&#xE4;sler R.; Ott S.; Baines J.F.; Schreiber S.; Rosenstiel P.; Nod2 is essential for temporal development of intestinal microbial communities. Gut 2011,60(10),1354-1362","journal-title":"Gut"},{"key":"ref=242","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.1172\/JCI72336","volume":"124","author":"Seekatz A.M.","year":"2014","unstructured":"Seekatz A.M.; Young V.B.; Clostridium difficile and the microbiota. J Clin Invest 2014,124(10),4182-4189","journal-title":"J Clin Invest"},{"key":"ref=243","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1378\/chest.06-3008","volume":"131","author":"Kozyrskyj A.L.","year":"2007","unstructured":"Kozyrskyj A.L.; Ernst P.; Becker A.B.; Increased risk of childhood asthma from antibiotic use in early life. Chest 2007,131(6),1753-1759","journal-title":"Chest"},{"key":"ref=244","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13073-016-0297-9","volume":"8","author":"Mahana D.","year":"2016","unstructured":"Mahana D.; Trent C.M.; Kurtz Z.D.; Bokulich N.A.; Battaglia T.; Chung J.; M&#xFC;ller C.L.; Li H.; Bonneau R.A.; Blaser M.J.; Antibiotic perturbation of the murine gut microbiome enhances the adiposity, insulin resistance, and liver disease associated with high-fat diet. Genome Med 2016,8(1),48","journal-title":"Genome Med"},{"key":"ref=245","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1139\/bcb-2014-0107","volume":"93","author":"Chang W.","year":"2015","unstructured":"Chang W.; Chen L.; Hatch G.M.; Berberine as a therapy for type 2 diabetes and its complications: From mechanism of action to clinical studies. Biochem Cell Biol 2015,93(5),479-486","journal-title":"Biochem Cell Biol"},{"key":"ref=246","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1136\/gutjnl-2012-303839","volume":"63","author":"Shin N.R.","year":"2014","unstructured":"Shin N.R.; Lee J.C.; Lee H.Y.; Kim M.S.; Whon T.W.; Lee M.S.; Bae J.W.; An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 2014,63(5),727-735","journal-title":"Gut"},{"key":"ref=247","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.2337\/dc10-0556","volume":"33","author":"Musso G.","year":"2010","unstructured":"Musso G.; Gambino R.; Cassader M.; Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? Diabetes Care 2010,33(10),2277-2284","journal-title":"Diabetes Care"},{"key":"ref=248","doi-asserted-by":"publisher","first-page":"9066","DOI":"10.1073\/pnas.1219451110","volume":"110","author":"Everard A.","year":"2013","unstructured":"Everard A.; Belzer C.; Geurts L.; Ouwerkerk J.P.; Druart C.; Bindels L.B.; Guiot Y.; Derrien M.; Muccioli G.G.; Delzenne N.M.; de Vos W.M.; Cani P.D.; Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA 2013,110(22),9066-9071","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=249","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","volume":"165","author":"Koh A.","year":"2016","unstructured":"Koh A.; De Vadder F.; Kovatcheva-Datchary P.; B&#xE4;ckhed F.; From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. Cell 2016,165(6),1332-1345","journal-title":"Cell"},{"key":"ref=250","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ijfoodmicro.2007.11.042","volume":"122","author":"Uyeno Y.","year":"2008","unstructured":"Uyeno Y.; Sekiguchi Y.; Kamagata Y.; Impact of consumption of probiotic lactobacilli-containing yogurt on microbial composition in human feces. Int J Food Microbiol 2008,122(1-2),16-22","journal-title":"Int J Food Microbiol"},{"key":"ref=251","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1017\/S0022029906002068","volume":"73","author":"Olivares M.","year":"2006","unstructured":"Olivares M.; Paz D&#xED;az-Ropero M.; G&#xF3;mez N.; Sierra S.; Lara-Villoslada F.; Mart&#xED;n R.; Miguel Rodr&#xED;guez J.; Xaus J.; Dietary deprivation of fermented foods causes a fall in innate immune response. Lactic acid bacteria can counteract the immunological effect of this deprivation. J Dairy Res 2006,73(4),492-498","journal-title":"J Dairy Res"},{"key":"ref=252","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nm.4236","volume":"23","author":"Plovier H.","year":"2017","unstructured":"Plovier H.; Everard A.; Druart C.; Depommier C.; Van Hul M.; Geurts L.; Chilloux J.; Ottman N.; Duparc T.; Lichtenstein L.; Myridakis A.; Delzenne N.M.; Klievink J.; Bhattacharjee A.; van der Ark K.C.H.; Aalvink S.; Martinez L.O.; Dumas M.E.; Maiter D.; Loumaye A.; Hermans M.P.; Thissen J.P.; Belzer C.; de Vos W.M.; Cani P.D.; A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med 2017,23(1),107-113","journal-title":"Nat Med"},{"key":"ref=253","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1111\/jgh.14144","volume":"33","author":"Shen Z.","year":"2018","unstructured":"Shen Z.; Zhu C.; Quan Y.; Yang J.; Yuan W.; Yang Z.; Wu S.; Luo W.; Tan B.; Wang X.; Insights into Roseburia intestinalis which alleviates experimental colitis pathology by inducing anti-inflammatory responses. J Gastroenterol Hepatol 2018,33(10),1751-1760","journal-title":"J Gastroenterol Hepatol"},{"key":"ref=254","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/fty028","volume":"76","author":"Zhang L.","year":"2018","unstructured":"Zhang L.; Qin Q.; Liu M.; Zhang X.; He F.; Wang G.; Akkermansia muciniphila can reduce the damage of gluco\/lipotoxicity, oxidative stress and inflammation, and normalize intestine microbiota in streptozotocin-induced diabetic rats. Pathog Dis 2018,76(4)","journal-title":"Pathog Dis"},{"key":"ref=255","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/S0016-5085(00)70142-9","volume":"118","author":"Inan M.S.","year":"2000","unstructured":"Inan M.S.; Rasoulpour R.J.; Yin L.; Hubbard A.K.; Rosenberg D.W.; Giardina C.; The luminal short-chain fatty acid butyrate modulates NF-&#x3BA;B activity in a human colonic epithelial cell line. Gastroenterology 2000,118(4),724-734","journal-title":"Gastroenterology"},{"key":"ref=256","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1161\/CIRCULATIONAHA.118.033714","volume":"138","author":"Yoshida N.","year":"2018","unstructured":"Yoshida N.; Emoto T.; Yamashita T.; Watanabe H.; Hayashi T.; Tabata T.; Hoshi N.; Hatano N.; Ozawa G.; Sasaki N.; Mizoguchi T.; Amin H.Z.; Hirota Y.; Ogawa W.; Yamada T.; Hirata K.; Bacteroides vulgatus and Bacteroides dorei reduce gut microbial lipopolysaccharide production and inhibit atherosclerosis. Circulation 2018,138(22),2486-2498","journal-title":"Circulation"},{"key":"ref=257","doi-asserted-by":"publisher","first-page":"e450","DOI":"10.1038\/emm.2017.282","volume":"50","author":"Chelakkot C.","year":"2018","unstructured":"Chelakkot C.; Choi Y.; Kim D.K.; Park H.T.; Ghim J.; Kwon Y.; Jeon J.; Kim M.S.; Jee Y.K.; Gho Y.S.; Park H.S.; Kim Y.K.; Ryu S.H.; Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions. Exp Mol Med 2018,50(2),e450-e450","journal-title":"Exp Mol Med"},{"key":"ref=258","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1111\/jam.12573","volume":"117","author":"Kim S.H.","year":"2014","unstructured":"Kim S.H.; Huh C.S.; Choi I.D.; Jeong J.W.; Ku H.K.; Ra J.H.; Kim T.Y.; Kim G.B.; Sim J.H.; Ahn Y.T.; The anti-diabetic activity of Bifidobacterium lactis HY8101 in vitro and in vivo. J Appl Microbiol 2014,117(3),834-845","journal-title":"J Appl Microbiol"},{"key":"ref=259","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054617","volume":"8","author":"Kang J.H.","year":"2013","unstructured":"Kang J.H.; Yun S.I.; Park M.H.; Park J.H.; Jeong S.Y.; Park H.O.; Anti-obesity effect of Lactobacillus gasseri BNR17 in high-sucrose diet-induced obese mice. PLoS One 2013,8(1)","journal-title":"PLoS One"},{"key":"ref=260","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.1039\/C8FO00081F","volume":"9","author":"Dang F.","year":"2018","unstructured":"Dang F.; Jiang Y.; Pan R.; Zhou Y.; Wu S.; Wang R.; Zhuang K.; Zhang W.; Li T.; Man C.; Administration of Lactobacillus paracasei ameliorates type 2 diabetes in mice. Food Funct 2018,9(7),3630-3639","journal-title":"Food Funct"},{"key":"ref=261","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1136\/gutjnl-2019-320105","volume":"69","author":"Wang L.","year":"2020","unstructured":"Wang L.; Tang L.; Feng Y.; Zhao S.; Han M.; Zhang C.; Yuan G.; Zhu J.; Cao S.; Wu Q.; Li L.; Zhang Z.; A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8 + T cells in mice. Gut 2020,69(11),1988-1997","journal-title":"Gut"},{"key":"ref=262","doi-asserted-by":"publisher","first-page":"S156","DOI":"10.1097\/MCG.0b013e31817f184e","volume":"42","author":"Pineiro M.","year":"2008","unstructured":"Pineiro M.; Asp N.G.; Reid G.; Macfarlane S.; Morelli L.; Brunser O.; Tuohy K.; FAO Technical meeting on prebiotics. J Clin Gastroenterol 2008,42(8)(Suppl. 3),S156-S159","journal-title":"J Clin Gastroenterol"},{"key":"ref=263","doi-asserted-by":"publisher","first-page":"12079","DOI":"10.1111\/1758-2229.12079","volume":"2013","author":"Kim M-S.","year":"2013","unstructured":"Kim M-S.; Hwang S-S.; Park E-J.; Bae J-W.; Strict vegetarian diet improves the risk factors associated with metabolic diseases by modulating gut microbiota and reducing intestinal inflammation: Diet therapy, gut microbiota and metabolic diseases. Environ Microbiol Reports 2013,2013,12079","journal-title":"Environ Microbiol Reports"},{"key":"ref=264","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s00125-015-3844-9","volume":"59","author":"McCreight L.J.","year":"2016","unstructured":"McCreight L.J.; Bailey C.J.; Pearson E.R.; Metformin and the gastrointestinal tract. Diabetologia 2016,59(3),426-435","journal-title":"Diabetologia"},{"key":"ref=265","doi-asserted-by":"publisher","first-page":"328185","DOI":"10.1136\/gutjnl-2022-328185","volume":"2022","author":"Anh&#xEA; F.F.","year":"2022","unstructured":"Anh&#xEA; F.F.; Zlitni S.; Zhang S-Y.; Choi B. S-Y.; Chen C.Y.; Foley K.P.; Barra N.G.; Surette M.G.; Biertho L.; Richard D.; Tchernof A.; Lam T.K.T.; Marette A.; Schertzer J.; Human gut microbiota after bariatric surgery alters intestinal morphology and glucose absorption in mice independently of obesity. Gut 2022,2022,328185","journal-title":"Gut"},{"key":"ref=266","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/MOT.0b013e32834ee700","volume":"17","author":"Gruessner A.C.","year":"2012","unstructured":"Gruessner A.C.; Sutherland D.E.R.; Gruessner R.W.G.; Long-term outcome after pancreas transplantation. Curr Opin Organ Transplant 2012,17(1),100-105","journal-title":"Curr Opin Organ Transplant"},{"key":"ref=267","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/ajt.14558","volume":"18","author":"Kandaswamy R.","year":"2018","unstructured":"Kandaswamy R.; Stock P.G.; Gustafson S.K.; Skeans M.A.; Curry M.A.; Prentice M.A.; Fox A.; Israni A.K.; Snyder J.J.; Kasiske B.L.; OPTN\/SRTR 2016 Annual Data Report: Pancreas. Am J Transplant 2018,18(Suppl. 1),114-171","journal-title":"Am J Transplant"},{"key":"ref=268","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1056\/NEJM199807093390202","volume":"339","author":"Fioretto P.","year":"1998","unstructured":"Fioretto P.; Steffes M.W.; Sutherland D.E.R.; Goetz F.C.; Mauer M.; Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998,339(2),69-75","journal-title":"N Engl J Med"},{"key":"ref=269","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/nrendo.2016.178","volume":"13","author":"Shapiro A.M.J.","year":"2017","unstructured":"Shapiro A.M.J.; Pokrywczynska M.; Ricordi C.; Clinical pancreatic islet transplantation. Nat Rev Endocrinol 2017,13(5),268-277","journal-title":"Nat Rev Endocrinol"},{"key":"ref=270","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1056\/NEJMc070201","volume":"356","author":"Eich T.","year":"2007","unstructured":"Eich T.; Eriksson O.; Lundgren T.; Visualization of early engraftment in clinical islet transplantation by positron-emission tomography. N Engl J Med 2007,356(26),2754-2755","journal-title":"N Engl J Med"},{"key":"ref=271","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.2337\/dc12-0063","volume":"35","author":"Barton F.B.","year":"2012","unstructured":"Barton F.B.; Rickels M.R.; Alejandro R.; Hering B.J.; Wease S.; Naziruddin B.; Oberholzer J.; Odorico J.S.; Garfinkel M.R.; Levy M.; Pattou F.; Berney T.; Secchi A.; Messinger S.; Senior P.A.; Maffi P.; Posselt A.; Stock P.G.; Kaufman D.B.; Luo X.; Kandeel F.; Cagliero E.; Turgeon N.A.; Witkowski P.; Naji A.; O\u2019Connell P.J.; Greenbaum C.; Kudva Y.C.; Brayman K.L.; Aull M.J.; Larsen C.; Kay T.W.H.; Fernandez L.A.; Vantyghem M.C.; Bellin M.; Shapiro A.M.J.; Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care 2012,35(7),1436-1445","journal-title":"Diabetes Care"},{"key":"ref=272","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/ajt.13536","volume":"16","author":"Moassesfar S.","year":"2016","unstructured":"Moassesfar S.; Masharani U.; Frassetto L.A.; Szot G.L.; Tavakol M.; Stock P.G.; Posselt A.M.; A Comparative analysis of the safety, efficacy, and cost of islet versus pancreas transplantation in nonuremic patients with type 1 diabetes. Am J Transplant 2016,16(2),518-526","journal-title":"Am J Transplant"},{"key":"ref=273","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/nyas.12031","volume":"1281","author":"Weir G.C.","year":"2013","unstructured":"Weir G.C.; Bonner-Weir S.; Islet &#x3B2; cell mass in diabetes and how it relates to function, birth, and death. Ann N Y Acad Sci 2013,1281(1),92-105","journal-title":"Ann N Y Acad Sci"},{"key":"ref=274","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cmet.2017.08.007","volume":"27","author":"Aguayo-Mazzucato C.","year":"2018","unstructured":"Aguayo-Mazzucato C.; Bonner-Weir S.; Pancreatic &#x3B2; cell regeneration as a possible therapy for diabetes. Cell Metab 2018,27(1),57-67","journal-title":"Cell Metab"},{"key":"ref=275","doi-asserted-by":"publisher","first-page":"710","DOI":"10.2337\/diabetes.50.4.710","volume":"50","author":"Ryan E.A.","year":"2001","unstructured":"Ryan E.A.; Lakey J.R.T.; Rajotte R.V.; Korbutt G.S.; Kin T.; Imes S.; Rabinovitch A.; Elliott J.F.; Bigam D.; Kneteman N.M.; Warnock G.L.; Larsen I.; Shapiro A.M.J.; Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001,50(4),710-719","journal-title":"Diabetes"},{"key":"ref=276","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJM200007273430401","volume":"343","author":"Shapiro A.M.J.","year":"2000","unstructured":"Shapiro A.M.J.; Lakey J.R.T.; Ryan E.A.; Korbutt G.S.; Toth E.; Warnock G.L.; Kneteman N.M.; Rajotte R.V.; Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000,343(4),230-238","journal-title":"N Engl J Med"},{"key":"ref=277","doi-asserted-by":"publisher","first-page":"17444","DOI":"10.1073\/pnas.0608141103","volume":"103","author":"Keymeulen B.","year":"2006","unstructured":"Keymeulen B.; Gillard P.; Mathieu C.; Movahedi B.; Maleux G.; Delvaux G.; Ysebaert D.; Roep B.; Vandemeulebroucke E.; Marichal M.; In \u2019t Veld, P.; Bogdani, M.; Hendrieckx, C.; Gorus, F.; Ling, Z.; van Rood, J.; Pipeleers, D. Correlation between &#x3B2; cell mass and glycemic control in type 1 diabetic recipients of islet cell graft. Proc Natl Acad Sci USA 2006,103(46),17444-17449","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=278","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13287-019-1165-5","volume":"10","author":"Zakrzewski W.","year":"2019","unstructured":"Zakrzewski W.; Dobrzy\u0144ski M.; Szymonowicz M.; Rybak Z.; Stem cells: Past, present, and future. Stem Cell Res Ther 2019,10(1),68","journal-title":"Stem Cell Res Ther"},{"key":"ref=279","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/JCN.0b013e318197a6a5","volume":"24","author":"Biehl J.K.","year":"2009","unstructured":"Biehl J.K.; Russell B.; Introduction to stem cell therapy. J Cardiovasc Nurs 2009,24(2),98-103","journal-title":"J Cardiovasc Nurs"},{"key":"ref=280","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/kisup.2011.15","volume":"1","author":"Chagastelles P.C.","year":"2011","unstructured":"Chagastelles P.C.; Nardi N.B.; Biology of stem cells: An overview. Kidney Int Suppl 2011,1(3),63-67","journal-title":"Kidney Int Suppl"},{"key":"ref=281","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2147\/SCCAA.S304887","volume":"14","author":"Worku M.G.","year":"2021","unstructured":"Worku M.G.; Pluripotent and multipotent stem cells and current therapeutic applications: Review Stem Cells Cloning 2021,14,3-7","journal-title":"Stem Cells Cloning"},{"key":"ref=282","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.3727\/096368908787236549","volume":"17","author":"Naujok O.","year":"2008","unstructured":"Naujok O.; Francini F.; Picton S.; J&#xF6;rns A.; Bailey C.J.; Lenzen S.; A new experimental protocol for preferential differentiation of mouse embryonic stem cells into insulin-producing cells. Cell Transplant 2008,17(10-11),1231-1242","journal-title":"Cell Transplant"},{"key":"ref=283","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nbt1393","volume":"26","author":"Kroon E.","year":"2008","unstructured":"Kroon E.; Martinson L.A.; Kadoya K.; Bang A.G.; Kelly O.G.; Eliazer S.; Young H.; Richardson M.; Smart N.G.; Cunningham J.; Agulnick A.D.; D\u2019Amour K.A.; Carpenter M.K.; Baetge E.E.; Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol 2008,26(4),443-452","journal-title":"Nat Biotechnol"},{"key":"ref=284","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jsps.2013.12.012","volume":"23","author":"Sheik Abdulazeez S.","year":"2015","unstructured":"Sheik Abdulazeez S.; Diabetes treatment: A rapid review of the current and future scope of stem cell research. Saudi Pharm J 2015,23(4),333-340","journal-title":"Saudi Pharm J"},{"key":"ref=285","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s13287-018-1038-3","volume":"9","author":"Ida H.","year":"2018","unstructured":"Ida H.; Akiyama T.; Ishiguro K.; Goparaju S.K.; Nakatake Y.; Chikazawa-Nohtomi N.; Sato S.; Kimura H.; Yokoyama Y.; Nagino M.; Ko M.S.H.; Ko S.B.H.; Establishment of a rapid and footprint-free protocol for differentiation of human embryonic stem cells into pancreatic endocrine cells with synthetic mRNAs encoding transcription factors. Stem Cell Res Ther 2018,9(1),277","journal-title":"Stem Cell Res Ther"},{"key":"ref=286","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nprot.2006.71","volume":"1","author":"Schroeder I.S.","year":"2006","unstructured":"Schroeder I.S.; Rolletschek A.; Blyszczuk P.; Kania G.; Wobus A.M.; Differentiation of mouse embryonic stem cells to insulin-producing cells. Nat Protoc 2006,1(2),495-507","journal-title":"Nat Protoc"},{"key":"ref=287","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/jmcb\/mjp037","volume":"2","author":"Cai J.","year":"2010","unstructured":"Cai J.; Yu C.; Liu Y.; Chen S.; Guo Y.; Yong J.; Lu W.; Ding M.; Deng H.; Generation of homogeneous PDX1(+) pancreatic progenitors from human ES cell-derived endoderm cells. J Mol Cell Biol 2010,2(1),50-60","journal-title":"J Mol Cell Biol"},{"key":"ref=288","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nm.4030","volume":"22","author":"Vegas A.J.","year":"2016","unstructured":"Vegas A.J.; Veiseh O.; G&#xFC;rtler M.; Millman J.R.; Pagliuca F.W.; Bader A.R.; Doloff J.C.; Li J.; Chen M.; Olejnik K.; Tam H.H.; Jhunjhunwala S.; Langan E.; Aresta-Dasilva S.; Gandham S.; McGarrigle J.J.; Bochenek M.A.; Hollister-Lock J.; Oberholzer J.; Greiner D.L.; Weir G.C.; Melton D.A.; Langer R.; Anderson D.G.; Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice. Nat Med 2016,22(3),306-311","journal-title":"Nat Med"},{"key":"ref=289","doi-asserted-by":"publisher","first-page":"ldv045","DOI":"10.1093\/bmb\/ldv045","volume":"116","author":"Ilic D.","year":"2015","unstructured":"Ilic D.; Devito L.; Miere C.; Codognotto S.; Human embryonic and induced pluripotent stem cells in clinical trials: Table 1. Br Med Bull 2015,116,ldv045","journal-title":"Br Med Bull"},{"key":"ref=290","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"Takahashi K.","year":"2006","unstructured":"Takahashi K.; Yamanaka S.; Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006,126(4),663-676","journal-title":"Cell"},{"key":"ref=291","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"Yu J.","year":"2007","unstructured":"Yu J.; Vodyanik M.A.; Smuga-Otto K.; Antosiewicz-Bourget J.; Frane J.L.; Tian S.; Nie J.; Jonsdottir G.A.; Ruotti V.; Stewart R.; Slukvin I.I.; Thomson J.A.; Induced pluripotent stem cell lines derived from human somatic cells. Science 2007,318(5858),1917-1920","journal-title":"Science"},{"key":"ref=292","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3858\/emm.2012.44.3.015","volume":"44","author":"Jang J.","year":"2012","unstructured":"Jang J.; Yoo J.E.; Lee J.A.; Lee D.R.; Kim J.Y.; Huh Y.J.; Kim D.S.; Park C.Y.; Hwang D.Y.; Kim H.S.; Kang H.C.; Kim D.W.; Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discovery. Exp Mol Med 2012,44(3),202-213","journal-title":"Exp Mol Med"},{"key":"ref=293","doi-asserted-by":"publisher","first-page":"13426","DOI":"10.1073\/pnas.1007884107","volume":"107","author":"Alipio Z.","year":"2010","unstructured":"Alipio Z.; Liao W.; Roemer E.J.; Waner M.; Fink L.M.; Ward D.C.; Ma Y.; Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic &#x3B2;-like cells. Proc Natl Acad Sci USA 2010,107(30),13426-13431","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=294","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/cr.2009.28","volume":"19","author":"Zhang D.","year":"2009","unstructured":"Zhang D.; Jiang W.; Liu M.; Sui X.; Yin X.; Chen S.; Shi Y.; Deng H.; Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res 2009,19(4),429-438","journal-title":"Cell Res"},{"key":"ref=295","doi-asserted-by":"publisher","first-page":"5353","DOI":"10.1074\/jbc.C112.428979","volume":"288","author":"Teo A.K.K.","year":"2013","unstructured":"Teo A.K.K.; Windmueller R.; Johansson B.B.; Dirice E.; Njolstad P.R.; Tjora E.; Raeder H.; Kulkarni R.N.; Derivation of human induced pluripotent stem cells from patients with maturity onset diabetes of the young. J Biol Chem 2013,288(8),5353-5356","journal-title":"J Biol Chem"},{"key":"ref=296","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116582","volume":"10","author":"Raikwar S.P.","year":"2015","unstructured":"Raikwar S.P.; Kim E.M.; Sivitz W.I.; Allamargot C.; Thedens D.R.; Zavazava N.; Human iPS cell-derived insulin producing cells form vascularized organoids under the kidney capsules of diabetic mice. PLoS One 2015,10(1)","journal-title":"PLoS One"},{"key":"ref=297","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.stemcr.2017.05.019","volume":"8","author":"Trott J.","year":"2017","unstructured":"Trott J.; Tan E.K.; Ong S.; Titmarsh D.M.; Denil S.L.I.J.; Giam M.; Wong C.K.; Wang J.; Shboul M.; Eio M.; Cooper-White J.; Cool S.M.; Rancati G.; Stanton L.W.; Reversade B.; Dunn N.R.; Long-Term culture of self-renewing pancreatic progenitors derived from human pluripotent stem cells. Stem Cell Reports 2017,8(6),1675-1688","journal-title":"Stem Cell Reports"},{"key":"ref=298","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cell.2014.09.040","volume":"159","author":"Pagliuca F.W.","year":"2014","unstructured":"Pagliuca F.W.; Millman J.R.; G&#xFC;rtler M.; Segel M.; Van Dervort A.; Ryu J.H.; Peterson Q.P.; Greiner D.; Melton D.A.; Generation of functional human pancreatic &#x3B2; cells in vitro. Cell 2014,159(2),428-439","journal-title":"Cell"},{"key":"ref=299","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085336","volume":"9","author":"Kanemura H.","year":"2014","unstructured":"Kanemura H.; Go M.J.; Shikamura M.; Nishishita N.; Sakai N.; Kamao H.; Mandai M.; Morinaga C.; Takahashi M.; Kawamata S.; Tumorigenicity studies of induced pluripotent stem cell (iPSC)-derived retinal pigment epithelium (RPE) for the treatment of age-related macular degeneration. PLoS One 2014,9(1)","journal-title":"PLoS One"},{"key":"ref=300","first-page":"22","volume":"4","author":"Calafiore R.","year":"2015","unstructured":"Calafiore R.; Basta G.; Stem cells for the cell and molecular therapy of type 1 diabetes mellitus (T1D): the gap between dream and reality. Am J Stem Cells 2015,4(1),22-31","journal-title":"Am J Stem Cells"},{"key":"ref=301","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2007.04.211","volume":"360","author":"Chen P.Y.","year":"2007","unstructured":"Chen P.Y.; Huang L.L.H.; Hsieh H.J.; Hyaluronan preserves the proliferation and differentiation potentials of long-term cultured murine adipose-derived stromal cells. Biochem Biophys Res Commun 2007,360(1),1-6","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=302","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/acel.12567","volume":"16","author":"Wong T.Y.","year":"2017","unstructured":"Wong T.Y.; Chang C.H.; Yu C.H.; Huang L.L.H.; Hyaluronan keeps mesenchymal stem cells quiescent and maintains the differentiation potential over time. Aging Cell 2017,16(3),451-460","journal-title":"Aging Cell"},{"key":"ref=303","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1002\/stem.2404","volume":"34","author":"Solis M.A.","year":"2016","unstructured":"Solis M.A.; Wei Y.H.; Chang C.H.; Yu C.H.; Kuo P.L.; Huang L.L.H.; Hyaluronan upregulates mitochondrial biogenesis and reduces adenoside triphosphate production for efficient mitochondrial function in slow-proliferating human mesenchymal stem cells. Stem Cells 2016,34(10),2512-2524","journal-title":"Stem Cells"},{"key":"ref=304","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00441-009-0780-3","volume":"336","author":"Liu C.M.","year":"2009","unstructured":"Liu C.M.; Chang C.H.; Yu C.H.; Hsu C.C.; Huang L.L.H.; Hyaluronan substratum induces multidrug resistance in human mesenchymal stem cells via CD44 signaling. Cell Tissue Res 2009,336(3),465-475","journal-title":"Cell Tissue Res"},{"key":"ref=305","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4252\/wjsc.v6.i2.163","volume":"6","author":"Figliuzzi M.","year":"2014","unstructured":"Figliuzzi M.; Bonandrini B.; Silvani S.; Remuzzi A.; Mesenchymal stem cells help pancreatic islet transplantation to control type 1 diabetes. World J Stem Cells 2014,6(2),163-172","journal-title":"World J Stem Cells"},{"key":"ref=306","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1097\/01.ASN.0000128974.07460.34","volume":"15","author":"Morigi M.","year":"2004","unstructured":"Morigi M.; Imberti B.; Zoja C.; Corna D.; Tomasoni S.; Abbate M.; Rottoli D.; Angioletti S.; Benigni A.; Perico N.; Alison M.; Remuzzi G.; Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol 2004,15(7),1794-1804","journal-title":"J Am Soc Nephrol"},{"key":"ref=307","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1365-2133.2005.06554.x","volume":"153","author":"Nakagawa H.","year":"2005","unstructured":"Nakagawa H.; Akita S.; Fukui M.; Fujii T.; Akino K.; Human mesenchymal stem cells successfully improve skin-substitute wound healing. Br J Dermatol 2005,153(1),29-36","journal-title":"Br J Dermatol"},{"key":"ref=308","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.1523\/JNEUROSCI.5060-03.2004","volume":"24","author":"Mu&#xF1;oz-Elias G.","year":"2004","unstructured":"Mu&#xF1;oz-Elias G.; Marcus A.J.; Coyne T.M.; Woodbury D.; Black I.B.; Adult bone marrow stromal cells in the embryonic brain: Engraftment, migration, differentiation, and long-term survival. J Neurosci 2004,24(19),4585-4595","journal-title":"J Neurosci"},{"key":"ref=309","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1172\/JCI0215182","volume":"109","author":"Schwartz R.E.","year":"2002","unstructured":"Schwartz R.E.; Reyes M.; Koodie L.; Jiang Y.; Blackstad M.; Lund T.; Lenvik T.; Johnson S.; Hu W.S.; Verfaillie C.M.; Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest 2002,109(10),1291-1302","journal-title":"J Clin Invest"},{"key":"ref=310","doi-asserted-by":"publisher","first-page":"115","DOI":"10.15283\/ijsc.2009.2.2.115","volume":"2","author":"Jun H.S.","year":"2009","unstructured":"Jun H.S.; Park E.Y.; Adult stem cells as a renewable source of insulin-producing cells. Int J Stem Cells 2009,2(2),115-121","journal-title":"Int J Stem Cells"},{"key":"ref=311","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1097\/TP.0b013e3181cb3e8d","volume":"89","author":"Sakata N.","year":"2010","unstructured":"Sakata N.; Chan N.K.; Chrisler J.; Obenaus A.; Hathout E.; Bone marrow cell cotransplantation with islets improves their vascularization and function. Transplantation 2010,89(6),686-693","journal-title":"Transplantation"},{"key":"ref=312","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.mce.2014.03.004","volume":"388","author":"Gao X.","year":"2014","unstructured":"Gao X.; Song L.; Shen K.; Wang H.; Qian M.; Niu W.; Qin X.; Bone marrow mesenchymal stem cells promote the repair of islets from diabetic mice through paracrine actions. Mol Cell Endocrinol 2014,388(1-2),41-50","journal-title":"Mol Cell Endocrinol"},{"key":"ref=313","first-page":"1017","volume":"91","author":"Lu L-L.","year":"2006","unstructured":"Lu L-L.; Liu Y-J.; Yang S-G.; Zhao Q-J.; Wang X.; Gong W.; Han Z-B.; Xu Z-S.; Lu Y-X.; Liu D.; Chen Z-Z.; Han Z-C.; Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 2006,91(8),1017-1026","journal-title":"Haematologica"},{"key":"ref=314","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.trre.2012.11.003","volume":"27","author":"Hematti P.","year":"2013","unstructured":"Hematti P.; Kim J.; Stein A.P.; Kaufman D.; Potential role of mesenchymal stromal cells in pancreatic islet transplantation. Transplant Rev (Orlando) 2013,27(1),21-29","journal-title":"Transplant Rev (Orlando)"},{"key":"ref=315","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.2337\/diabetes.53.7.1721","volume":"53","author":"Tang D.Q.","year":"2004","unstructured":"Tang D.Q.; Cao L.Z.; Burkhardt B.R.; Xia C.Q.; Litherland S.A.; Atkinson M.A.; Yang L.J.; In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes 2004,53(7),1721-1732","journal-title":"Diabetes"},{"key":"ref=316","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1634\/stemcells.2007-0164","volume":"25","author":"Karnieli O.","year":"2007","unstructured":"Karnieli O.; Izhar-Prato Y.; Bulvik S.; Efrat S.; Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation. Stem Cells 2007,25(11),2837-2844","journal-title":"Stem Cells"},{"key":"ref=317","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/stem.556","volume":"29","author":"Volarevic V.","year":"2011","unstructured":"Volarevic V.; Arsenijevic N.; Lukic M.L.; Stojkovic M.; Concise review: Mesenchymal stem cell treatment of the complications of diabetes mellitus. Stem Cells 2011,29(1),5-10","journal-title":"Stem Cells"},{"key":"ref=318","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1073\/pnas.85.1.116","volume":"85","author":"Welsh M.","year":"1988","unstructured":"Welsh M.; Welsh N.; Nilsson T.; Arkhammar P.; Pepinsky R.B.; Steiner D.F.; Berggren P.O.; Stimulation of pancreatic islet beta-cell replication by oncogenes. Proc Natl Acad Sci USA 1988,85(1),116-120","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=319","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fcell.2014.00009","volume":"2","author":"Li M.","year":"2014","unstructured":"Li M.; Ikehara S.; Stem cell treatment for type 1 diabetes. Front Cell Dev Biol 2014,2,9","journal-title":"Front Cell Dev Biol"},{"key":"ref=320","first-page":"91","volume":"1","author":"Armita Mahdavi Gorabi A.","year":"2016","unstructured":"Armita Mahdavi Gorabi A.; Jahandideh K.; Mesenchymal Stem Cells (M.S.C.) Effect in Streptozotocin (STZ) induced type I diabetic rats. Caspian Sea Journal 2016,1,91-95","journal-title":"Caspian Sea Journal"},{"key":"ref=321","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1172\/JCI200316502","volume":"111","author":"Ianus A.","year":"2003","unstructured":"Ianus A.; Holz G.G.; Theise N.D.; Hussain M.A.; In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 2003,111(6),843-850","journal-title":"J Clin Invest"},{"key":"ref=322","doi-asserted-by":"publisher","first-page":"3","DOI":"10.7603\/s40730-015-0003-3","volume":"2","author":"Dang L.T.T.","year":"2015","unstructured":"Dang L.T.T.; Bui A.N.T.; Pham V.M.; Phan N.K.; Van Pham P.; Production of islet-like insulin-producing cell clusters in vitro from adiposederived stem cells. Biomed Res Ther 2015,2(1),3","journal-title":"Biomed Res Ther"},{"key":"ref=323","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/675103","volume":"2015","author":"Hashemian S.J.","year":"2015","unstructured":"Hashemian S.J.; Kouhnavard M.; Nasli-Esfahani E.; Mesenchymal stem cells: Rising concerns over their application in treatment of type one Diabetes Mellitus. J Diabetes Res 2015,2015,1-19","journal-title":"J Diabetes Res"},{"key":"ref=324","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1900\/RDS.2010.7.168","volume":"7","author":"Kadam S.","year":"2010","unstructured":"Kadam S.; Muthyala S.; Nair P.; Bhonde R.; Human placenta-derived mesenchymal stem cells and islet-like cell clusters generated from these cells as a novel source for stem cell therapy in diabetes. Rev Diabet Stud 2010,7(2),168-182","journal-title":"Rev Diabet Stud"},{"key":"ref=325","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.bbrc.2004.06.121","volume":"321","author":"Ende N.","year":"2004","unstructured":"Ende N.; Chen R.; Reddi A.S.; Transplantation of human umbilical cord blood cells improves glycemia and glomerular hypertrophy in type 2 diabetic mice. Biochem Biophys Res Commun 2004,321(1),168-171","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=326","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1634\/stemcells.22-4-625","volume":"22","author":"Bieback K.","year":"2004","unstructured":"Bieback K.; Kern S.; Kl&#xFC;ter H.; Eichler H.; Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 2004,22(4),625-634","journal-title":"Stem Cells"},{"key":"ref=327","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1900\/RDS.2005.2.228","volume":"2","author":"Koblas T.","year":"2005","unstructured":"Koblas T.; Harman S.M.; Saudek F.; The application of umbilical cord blood cells in the treatment of diabetes mellitus. Rev Diabet Stud 2005,2(4),228-234","journal-title":"Rev Diabet Stud"},{"key":"ref=328","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3727\/096368911X612530","volume":"21","author":"Prabakar K.R.","year":"2012","unstructured":"Prabakar K.R.; Dom&#xED;nguez-Bendala J.; Molano R.D.; Pileggi A.; Villate S.; Ricordi C.; Inverardi L.; Generation of glucose-responsive, insulin-producing cells from human umbilical cord blood-derived mesenchymal stem cells. Cell Transplant 2012,21(6),1321-1339","journal-title":"Cell Transplant"},{"key":"ref=329","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1089\/ten.tea.2008.0579","volume":"15","author":"Wu L.F.","year":"2009","unstructured":"Wu L.F.; Wang N.N.; Liu Y.S.; Wei X.; Differentiation of Wharton\u2019s jelly primitive stromal cells into insulin-producing cells in comparison with bone marrow mesenchymal stem cells. Tissue Eng Part A 2009,15(10),2865-2873","journal-title":"Tissue Eng Part A"},{"key":"ref=330","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3892\/ijmm.2011.774","volume":"28","author":"He D.","year":"2011","unstructured":"He D.; Wang J.; Gao Y.; Zhang Y.; Differentiation of PDX1 gene-modified human umbilical cord mesenchymal stem cells into insulin-producing cells in vitro. Int J Mol Med 2011,28(6),1019-1024","journal-title":"Int J Mol Med"},{"key":"ref=331","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1423-0127-19-47","volume":"19","author":"Tsai P.J.","year":"2012","unstructured":"Tsai P.J.; Wang H.S.; Shyr Y.M.; Weng Z.C.; Tai L.C.; Shyu J.F.; Chen T.H.; Transplantation of insulin-producing cells from umbilical cord mesenchymal stem cells for the treatment of streptozotocin-induced diabetic rats. J Biomed Sci 2012,19(1),47","journal-title":"J Biomed Sci"},{"key":"ref=332","doi-asserted-by":"publisher","first-page":"31601","DOI":"10.1074\/jbc.M806597200","volume":"283","author":"Tateishi K.","year":"2008","unstructured":"Tateishi K.; He J.; Taranova O.; Liang G.; D\u2019Alessio A.C.; Zhang Y.; Generation of insulin-secreting islet-like clusters from human skin fibroblasts. J Biol Chem 2008,283(46),31601-31607","journal-title":"J Biol Chem"},{"key":"ref=333","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/labinvest.3700377","volume":"86","author":"Seeberger K.L.","year":"2006","unstructured":"Seeberger K.L.; Dufour J.M.; Shapiro A.M.J.; Lakey J.R.T.; Rajotte R.V.; Korbutt G.S.; Expansion of mesenchymal stem cells from human pancreatic ductal epithelium. Lab Invest 2006,86(2),141-153","journal-title":"Lab Invest"},{"key":"ref=334","first-page":"628","volume":"8","author":"Stagner J.I.","year":"2007","unstructured":"Stagner J.I.; Rilo H.L.; White K.K.; The pancreas as an islet transplantation site. Confirmation in a syngeneic rodent and canine autotransplant model. JOP 2007,8(5),628-636","journal-title":"JOP"},{"key":"ref=335","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.stemcr.2015.02.017","volume":"4","author":"Nostro M.C.","year":"2015","unstructured":"Nostro M.C.; Sarangi F.; Yang C.; Holland A.; Elefanty A.G.; Stanley E.G.; Greiner D.L.; Keller G.; Efficient generation of NKX6-1+ pancreatic progenitors from multiple human pluripotent stem cell lines. Stem Cell Reports 2015,4(4),591-604","journal-title":"Stem Cell Reports"},{"key":"ref=336","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.2337\/db11-1711","volume":"61","author":"Rezania A.","year":"2012","unstructured":"Rezania A.; Bruin J.E.; Riedel M.J.; Mojibian M.; Asadi A.; Xu J.; Gauvin R.; Narayan K.; Karanu F.; O\u2019Neil J.J.; Ao Z.; Warnock G.L.; Kieffer T.J.; Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice. Diabetes 2012,61(8),2016-2029","journal-title":"Diabetes"},{"key":"ref=337","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s12015-014-9503-6","volume":"10","author":"Abdelalim E.M.","year":"2014","unstructured":"Abdelalim E.M.; Bonnefond A.; Bennaceur-Griscelli A.; Froguel P.; Pluripotent stem cells as a potential tool for disease modelling and cell therapy in diabetes. Stem Cell Rev 2014,10(3),327-337","journal-title":"Stem Cell Rev"},{"key":"ref=338","doi-asserted-by":"publisher","first-page":"831","DOI":"10.2310\/JIM.0b013e3181ed3807","volume":"58","author":"Opara E.C.","year":"2010","unstructured":"Opara E.C.; Mirmalek-Sani S.H.; Khanna O.; Moya M.L.; Brey E.M.; Design of a bioartificial pancreas(+) J Investig Med 2010,58(7),831-837","journal-title":"J Investig Med"},{"key":"ref=339","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1089\/ten.tea.2008.0118","volume":"15","author":"Mallett A.G.","year":"2009","unstructured":"Mallett A.G.; Korbutt G.S.; Alginate modification improves long-term survival and function of transplanted encapsulated islets. Tissue Eng Part A 2009,15(6),1301-1309","journal-title":"Tissue Eng Part A"},{"key":"ref=340","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.1016\/j.actbio.2009.05.029","volume":"5","author":"Langlois G.","year":"2009","unstructured":"Langlois G.; Dusseault J.; Bilodeau S.; Tam S.K.; Magassouba D.; Hall&#xE9; J.P.; Direct effect of alginate purification on the survival of islets immobilized in alginate-based microcapsules. Acta Biomater 2009,5(9),3433-3440","journal-title":"Acta Biomater"},{"key":"ref=341","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nbt.3462","volume":"34","author":"Vegas A.J.","year":"2016","unstructured":"Vegas A.J.; Veiseh O.; Doloff J.C.; Ma M.; Tam H.H.; Bratlie K.; Li J.; Bader A.R.; Langan E.; Olejnik K.; Fenton P.; Kang J.W.; Hollister-Locke J.; Bochenek M.A.; Chiu A.; Siebert S.; Tang K.; Jhunjhunwala S.; Aresta-Dasilva S.; Dholakia N.; Thakrar R.; Vietti T.; Chen M.; Cohen J.; Siniakowicz K.; Qi M.; McGarrigle J.; Graham A.C.; Lyle S.; Harlan D.M.; Greiner D.L.; Oberholzer J.; Weir G.C.; Langer R.; Anderson D.G.; Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primates. Nat Biotechnol 2016,34(3),345-352","journal-title":"Nat Biotechnol"},{"key":"ref=342","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/ajt.13049","volume":"15","author":"Chen T.","year":"2015","unstructured":"Chen T.; Yuan J.; Duncanson S.; Hibert M.L.; Kodish B.C.; Mylavaganam G.; Maker M.; Li H.; Sremac M.; Santosuosso M.; Forbes B.; Kashiwagi S.; Cao J.; Lei J.; Thomas M.; Hartono C.; Sachs D.; Markmann J.; Sambanis A.; Poznansky M.C.; Alginate encapsulant incorporating CXCL12 supports long-term allo-and xenoislet transplantation without systemic immune suppression. Am J Transplant 2015,15(3),618-627","journal-title":"Am J Transplant"},{"key":"ref=343","doi-asserted-by":"publisher","first-page":"15308","DOI":"10.1111\/ajt.15308","volume":"2019","author":"Alagpulinsa D.A.","year":"2019","unstructured":"Alagpulinsa D.A.; Cao J.J.L.; Driscoll R.K.; S&#xEE;rbulescu R.F.; Penson M.F.E.; Sremac M.; Engquist E.N.; Brauns T.A.; Markmann J.F.; Melton D.A.; Poznansky M.C.; Alginate-microencapsulation of Human Stem Cell-Derived &#x3B2; Cells with CXCL 12 prolongs their survival and function in immunocompetent mice without systemic immunosuppression. Am J Transplant 2019,2019,15308","journal-title":"Am J Transplant"},{"key":"ref=344","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1900\/RDS.2011.8.51","volume":"8","author":"Vaithilingam V.","year":"2011","unstructured":"Vaithilingam V.; Tuch B.E.; Islet transplantation and encapsulation: an update on recent developments. Rev Diabet Stud 2011,8(1),51-67","journal-title":"Rev Diabet Stud"},{"key":"ref=345","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.2337\/dc09-0744","volume":"32","author":"Tuch B.E.","year":"2009","unstructured":"Tuch B.E.; Keogh G.W.; Williams L.J.; Wu W.; Foster J.L.; Vaithilingam V.; Philips R.; Safety and viability of microencapsulated human islets transplanted into diabetic humans. Diabetes Care 2009,32(10),1887-1889","journal-title":"Diabetes Care"},{"key":"ref=346","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/23808993.2017.1302305","volume":"2","author":"Paredes-Juarez G.A.","year":"2017","unstructured":"Paredes-Juarez G.A.; de Vos P.; Bulte J.W.M.; Recent progress in the use and tracking of transplanted islets as a personalized treatment for type 1 diabetes. Expert Rev Precis Med Drug Dev 2017,2(1),57-67","journal-title":"Expert Rev Precis Med Drug Dev"},{"key":"ref=347","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1073\/pnas.1400709111","volume":"111","author":"Hrvatin S.","year":"2014","unstructured":"Hrvatin S.; O\u2019Donnell C.W.; Deng F.; Millman J.R.; Pagliuca F.W.; DiIorio P.; Rezania A.; Gifford D.K.; Melton D.A.; Differentiated human stem cells resemble fetal, not adult, &#x3B2; cells. Proc Natl Acad Sci USA 2014,111(8),3038-3043","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=348","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.scr.2009.02.002","volume":"2","author":"Hentze H.","year":"2009","unstructured":"Hentze H.; Soong P.L.; Wang S.T.; Phillips B.W.; Putti T.C.; Dunn N.R.; Teratoma formation by human embryonic stem cells: Evaluation of essential parameters for future safety studies. Stem Cell Res (Amst) 2009,2(3),198-210","journal-title":"Stem Cell Res (Amst)"},{"key":"ref=349","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s00125-016-4125-y","volume":"60","author":"van der Torren C.R.","year":"2017","unstructured":"van der Torren C.R.; Zaldumbide A.; Duinkerken G.; Brand-Schaaf S.H.; Peakman M.; Stang&#xE9; G.; Martinson L.; Kroon E.; Brandon E.P.; Pipeleers D.; Roep B.O.; Immunogenicity of human embryonic stem cell-derived beta cells. Diabetologia 2017,60(1),126-133","journal-title":"Diabetologia"},{"key":"ref=350","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.stem.2019.02.005","volume":"24","author":"Xu H.","year":"2019","unstructured":"Xu H.; Wang B.; Ono M.; Kagita A.; Fujii K.; Sasakawa N.; Ueda T.; Gee P.; Nishikawa M.; Nomura M.; Kitaoka F.; Takahashi T.; Okita K.; Yoshida Y.; Kaneko S.; Hotta A.; Targeted disruption of HLA Genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility. Cell Stem Cell 2019,24(4),566-578.e7","journal-title":"Cell Stem Cell"},{"key":"ref=351","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/gt.2015.18","volume":"22","author":"El Khatib M.M.","year":"2015","unstructured":"El Khatib M.M.; Sakuma, T.; Tonne, J.M.; Mohamed, M.S.; Holditch, S.J.; Lu, B.; Kudva, Y.C.; Ikeda, Y. &#x3B2;-Cell-targeted blockage of PD1 and CTLA4 pathways prevents development of autoimmune diabetes and acute allogeneic islets rejection. Gene Ther 2015,22(5),430-438","journal-title":"Gene Ther"},{"key":"ref=352","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/sj.mt.6300190","volume":"15","author":"Bonini C.","year":"2007","unstructured":"Bonini C.; Bondanza A.; Perna S.K.; Kaneko S.; Traversari C.; Ciceri F.; Bordignon C.; The suicide gene therapy challenge: How to improve a successful gene therapy approach. Mol Ther 2007,15(7),1248-1252","journal-title":"Mol Ther"},{"key":"ref=353","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature02520","volume":"429","author":"Dor Y.","year":"2004","unstructured":"Dor Y.; Brown J.; Martinez O.I.; Melton D.A.; Adult pancreatic &#x3B2;-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004,429(6987),41-46","journal-title":"Nature"},{"key":"ref=354","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1172\/JCI22098","volume":"114","author":"Georgia S.","year":"2004","unstructured":"Georgia S.; Bhushan, A. &#x3B2; cell replication is the primary mechanism for maintaining postnatal &#x3B2; cell mass. J Clin Invest 2004,114(7),963-968","journal-title":"J Clin Invest"},{"key":"ref=355","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","volume":"52","author":"Butler A.E.","year":"2003","unstructured":"Butler A.E.; Janson, J.; Bonner-Weir, S.; Ritzel, R.; Rizza, R.A.; Butler, P.C. &#x3B2;-cell deficit and increased &#x3B2;-cell apoptosis in humans with type 2 diabetes. Diabetes 2003,52(1),102-110","journal-title":"Diabetes"},{"key":"ref=356","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1007\/s00125-005-1949-2","volume":"48","author":"Meier J.J.","year":"2005","unstructured":"Meier J.J.; Bhushan A.; Butler A.E.; Rizza R.A.; Butler P.C.; Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia 2005,48(11),2221-2228","journal-title":"Diabetologia"},{"key":"ref=357","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1152\/physrev.00025.2004","volume":"85","author":"Bouwens L.","year":"2005","unstructured":"Bouwens L.; Rooman I.; Regulation of pancreatic beta-cell mass. Physiol Rev 2005,85(4),1255-1270","journal-title":"Physiol Rev"},{"key":"ref=358","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1111\/j.1471-0528.1978.tb15835.x","volume":"85","author":"Assche F.A.","year":"1978","unstructured":"Assche F.A.; Aerts L.; Prins F.D.; A morphological study of the endocrine pancreas in human pregnancy. BJOG 1978,85(11),818-820","journal-title":"BJOG"},{"key":"ref=359","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1210\/jc.2004-0761","volume":"90","author":"Suarez-Pinzon W.L.","year":"2005","unstructured":"Suarez-Pinzon W.L.; Lakey J.R.T.; Brand S.J.; Rabinovitch A.; Combination therapy with epidermal growth factor and gastrin induces neogenesis of human islet &#x3B2;-cells from pancreatic duct cells and an increase in functional &#x3B2;-cell mass. J Clin Endocrinol Metab 2005,90(6),3401-3409","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=360","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00125-003-1287-1","volume":"47","author":"Rooman I.","year":"2004","unstructured":"Rooman I.; Bouwens L.; Combined gastrin and epidermal growth factor treatment induces islet regeneration and restores normoglycaemia in C57Bl6\/J mice treated with alloxan. Diabetologia 2004,47(2),259-265","journal-title":"Diabetologia"},{"key":"ref=361","doi-asserted-by":"publisher","first-page":"686","DOI":"10.2337\/diabetes.51.3.686","volume":"51","author":"Rooman I.","year":"2002","unstructured":"Rooman I.; Lardon J.; Bouwens L.; Gastrin stimulates &#x3B2;-cell neogenesis and increases islet mass from transdifferentiated but not from normal exocrine pancreas tissue. Diabetes 2002,51(3),686-690","journal-title":"Diabetes"},{"key":"ref=362","doi-asserted-by":"publisher","first-page":"124","DOI":"10.2337\/diabetes.52.1.124","volume":"52","author":"Buteau J.","year":"2003","unstructured":"Buteau J.; Foisy S.; Joly E.; Prentki M.; Glucagon-like peptide 1 induces pancreatic &#x3B2;-cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes 2003,52(1),124-132","journal-title":"Diabetes"},{"key":"ref=363","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/dmrr.538","volume":"21","author":"Meier J.J.","year":"2005","unstructured":"Meier J.J.; Nauck M.A.; Glucagon-like peptide 1(GLP-1) in biology and pathology. Diabetes Metab Res Rev 2005,21(2),91-117","journal-title":"Diabetes Metab Res Rev"},{"key":"ref=364","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1210\/me.15.9.1559","volume":"15","author":"Tr&#xFC;mper A.","year":"2001","unstructured":"Tr&#xFC;mper A.; Tr&#xFC;mper K.; Trusheim H.; Arnold R.; G&#xF6;ke B.; H&#xF6;rsch D.; Glucose-dependent insulinotropic polypeptide is a growth factor for &#x3B2; (INS-1) cells by pleiotropic signaling. Mol Endocrinol 2001,15(9),1559-1570","journal-title":"Mol Endocrinol"},{"key":"ref=365","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.2337\/diabetes.51.12.3435","volume":"51","author":"Beattie G.M.","year":"2002","unstructured":"Beattie G.M.; Montgomery A.M.P.; Lopez A.D.; Hao E.; Perez B.; Just M.L.; Lakey J.R.T.; Hart M.E.; Hayek A.; A novel approach to increase human islet cell mass while preserving &#x3B2;-cell function. Diabetes 2002,51(12),3435-3439","journal-title":"Diabetes"},{"key":"ref=366","doi-asserted-by":"publisher","first-page":"966","DOI":"10.2337\/diabetes.51.4.966","volume":"51","author":"Lingohr M.K.","year":"2002","unstructured":"Lingohr M.K.; Dickson L.M.; McCuaig J.F.; Hugl S.R.; Twardzik D.R.; Rhodes C.J.; Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-&#x3B1; or EGF, augments pancreatic &#x3B2;-cell proliferation. Diabetes 2002,51(4),966-976","journal-title":"Diabetes"},{"key":"ref=367","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2337\/diab.31.2.160","volume":"31","author":"Rabinovitch A.","year":"1982","unstructured":"Rabinovitch A.; Quigley C.; Russell T.; Patel Y.; Mintz D.H.; Insulin and multiplication stimulating activity (an insulin-like growth factor) stimulate islet (&#x3B2;-cell replication in neonatal rat pancreatic monolayer cultures. Diabetes 1982,31(2),160-164","journal-title":"Diabetes"},{"key":"ref=368","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1677\/jme.0.0240303","volume":"24","author":"Rhodes C.J.","year":"2000","unstructured":"Rhodes C.J.; IGF-I and GH post-receptor signaling mechanisms for pancreatic beta-cell replication. J Mol Endocrinol 2000,24(3),303-311","journal-title":"J Mol Endocrinol"},{"key":"ref=369","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1210\/endo.139.4.5882","volume":"139","author":"Huotari M.A.","year":"1998","unstructured":"Huotari M.A.; Palgi J.; Otonkoski T.; Growth factor-mediated proliferation and differentiation of insulin-producing INS-1 and RINm5F cells: identification of betacellulin as a novel &#x3B2;-cell mitogen. Endocrinology 1998,139(4),1494-1499","journal-title":"Endocrinology"},{"key":"ref=370","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1007\/s00125-003-1117-5","volume":"46","author":"Movassat J.","year":"2003","unstructured":"Movassat J.; Beattie G.M.; Lopez A.D.; Portha B.; Hayek A.; Keratinocyte growth factor and beta-cell differentiation in human fetal pancreatic endocrine precursor cells. Diabetologia 2003,46(6),822-829","journal-title":"Diabetologia"},{"key":"ref=371","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S1357-2725(00)00028-5","volume":"32","author":"Dunbar A.J.","year":"2000","unstructured":"Dunbar A.J.; Goddard C.; Structure-function and biological role of betacellulin. Int J Biochem Cell Biol 2000,32(8),805-815","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=372","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.2337\/diabetes.52.7.1701","volume":"52","author":"Ritzel R.A.","year":"2003","unstructured":"Ritzel R.A.; Butler P.C.; Replication increases &#x3B2;-cell vulnerability to human islet amyloid polypeptide-induced apoptosis. Diabetes 2003,52(7),1701-1708","journal-title":"Diabetes"},{"key":"ref=373","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00125-005-0069-3","volume":"49","author":"Meier J.J.","year":"2006","unstructured":"Meier J.J.; Ritzel R.A.; Maedler K.; Gurlo T.; Butler P.C.; Increased vulnerability of newly forming beta cells to cytokine-induced cell death. Diabetologia 2006,49(1),83-89","journal-title":"Diabetologia"},{"key":"ref=374","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s12022-015-9362-y","volume":"26","author":"Katuchova J.","year":"2015","unstructured":"Katuchova J.; Harvanova D.; Spakova T.; Kalanin R.; Farkas D.; Durny P.; Rosocha J.; Radonak J.; Petrovic D.; Siniscalco D.; Qi M.; Novak M.; Kruzliak P.; Mesenchymal stem cells in the treatment of type 1 diabetes mellitus. Endocr Pathol 2015,26(2),95-103","journal-title":"Endocr Pathol"},{"key":"ref=375","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.3892\/ijmm.2018.3501","volume":"41","author":"Li Y.","year":"2018","unstructured":"Li Y.; Liu J.; Liao G.; Zhang J.; Chen Y.; Li L.; Li L.; Liu F.; Chen B.; Guo G.; Wang C.; Yang L.; Cheng J.; Lu Y.; Early intervention with mesenchymal stem cells prevents nephropathy in diabetic rats by ameliorating the inflammatory microenvironment. Int J Mol Med 2018,41(5),2629-2639","journal-title":"Int J Mol Med"},{"key":"ref=376","doi-asserted-by":"publisher","first-page":"8484","DOI":"10.1038\/s41598-017-08921-y","volume":"7","author":"Nagaishi K.","year":"2017","unstructured":"Nagaishi K.; Mizue Y.; Chikenji T.; Otani M.; Nakano M.; Saijo Y.; Tsuchida H.; Ishioka S.; Nishikawa A.; Saito T.; Fujimiya M.; Umbilical cord extracts improve diabetic abnormalities in bone marrow-derived mesenchymal stem cells and increase their therapeutic effects on diabetic nephropathy. Sci Rep 2017,7(1),8484","journal-title":"Sci Rep"},{"key":"ref=377","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/cells7120226","volume":"7","author":"Ebrahim N.","year":"2018","unstructured":"Ebrahim N.; Ahmed I.; Hussien N.; Dessouky A.; Farid A.; Elshazly A.; Mostafa O.; Gazzar W.; Sorour S.; Seleem Y.; Hussein A.; Sabry D.; Mesenchymal Stem cell-derived exosomes ameliorated diabetic nephropathy by autophagy induction through the mTOR signaling pathway. Cells 2018,7(12),226","journal-title":"Cells"},{"key":"ref=378","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1139\/bcb-2017-0230","volume":"96","author":"Rashed L.A.","year":"2018","unstructured":"Rashed L.A.; Elattar S.; Eltablawy N.; Ashour H.; Mahmoud L.M.; El-Esawy Y.; Mesenchymal stem cells pretreated with melatonin ameliorate kidney functions in a rat model of diabetic nephropathy. Biochem Cell Biol 2018,96(5),564-571","journal-title":"Biochem Cell Biol"},{"key":"ref=379","doi-asserted-by":"publisher","first-page":"4840","DOI":"10.1111\/jcmm.13747","volume":"22","author":"Sun J.","year":"2018","unstructured":"Sun J.; Zhao F.; Zhang W.; Lv J.; Lv J.; Yin A.; BMSC s and miR-124a ameliorated diabetic nephropathy via inhibiting notch signalling pathway. J Cell Mol Med 2018,22(10),4840-4855","journal-title":"J Cell Mol Med"},{"key":"ref=380","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.lfs.2018.11.001","volume":"215","author":"Li H.","year":"2018","unstructured":"Li H.; Rong P.; Ma X.; Nie W.; Chen C.; Yang C.; Zhang J.; Dong Q.; Wang W.; Paracrine effect of mesenchymal stem cell as a novel therapeutic strategy for diabetic nephropathy. Life Sci 2018,215,113-118","journal-title":"Life Sci"},{"key":"ref=381","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1634\/stemcells.2005-0365","volume":"24","author":"Kim S.W.","year":"2006","unstructured":"Kim S.W.; Han H.; Chae G.T.; Lee S.H.; Bo S.; Yoon J.H.; Lee Y.S.; Lee K.S.; Park H.K.; Kang K.S.; Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger\u2019s disease and ischemic limb disease animal model. Stem Cells 2006,24(6),1620-1626","journal-title":"Stem Cells"},{"key":"ref=382","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1161\/CIRCRESAHA.111.242610","volume":"108","author":"Williams A.R.","year":"2011","unstructured":"Williams A.R.; Trachtenberg B.; Velazquez D.L.; McNiece I.; Altman P.; Rouy D.; Mendizabal A.M.; Pattany P.M.; Lopera G.A.; Fishman J.; Zambrano J.P.; Heldman A.W.; Hare J.M.; Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: Functional recovery and reverse remodeling. Circ Res 2011,108(7),792-796","journal-title":"Circ Res"},{"key":"ref=383","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.neulet.2015.04.038","volume":"597","author":"Xia N.","year":"2015","unstructured":"Xia N.; Xu J.M.; Zhao N.; Zhao Q.S.; Li M.; Cheng Z.F.; Human mesenchymal stem cells improve the neurodegeneration of femoral nerve in a diabetic foot ulceration rats. Neurosci Lett 2015,597,84-89","journal-title":"Neurosci Lett"},{"key":"ref=384","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1016\/j.ymthe.2018.03.017","volume":"26","author":"MacAskill M.G.","year":"2018","unstructured":"MacAskill M.G.; Saif J.; Condie A.; Jansen M.A.; MacGillivray T.J.; Tavares A.A.S.; Fleisinger L.; Spencer H.L.; Besnier M.; Martin E.; Biglino G.; Newby D.E.; Hadoke P.W.F.; Mountford J.C.; Emanueli C.; Baker A.H.; Robust revascularization in models of limb ischemia using a clinically translatable human stem cell-derived endothelial cell product. Mol Ther 2018,26(7),1669-1684","journal-title":"Mol Ther"},{"key":"ref=385","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3727\/096368916X692726","volume":"26","author":"Liang L.","year":"2017","unstructured":"Liang L.; Li Z.; Ma T.; Han Z.; Du W.; Geng J.; Jia H.; Zhao M.; Wang J.; Zhang B.; Feng J.; Zhao L.; Rupin A.; Wang Y.; Han Z.C.; Transplantation of Human placenta-derived mesenchymal stem cells alleviates critical limb ischemia in diabetic nude rats. Cell Transplant 2017,26(1),45-61","journal-title":"Cell Transplant"},{"key":"ref=386","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.1111\/aos.12113","volume":"92","author":"Ezquer F.","year":"2014","unstructured":"Ezquer F.; Ezquer M.; Arango-Rodriguez M.; Conget P.; Could donor multipotent mesenchymal stromal cells prevent or delay the onset of diabetic retinopathy? Acta Ophthalmol 2014,92(2),e86-e95","journal-title":"Acta Ophthalmol"},{"key":"ref=387","doi-asserted-by":"publisher","first-page":"41","DOI":"10.18240\/ijo.2016.01.07","volume":"9","author":"Chen S.","year":"2016","unstructured":"Chen S.; Zhang W.; Wang J-M.; Duan H-T.; Kong J-H.; Wang Y-X.; Dong M.; Bi X.; Song J.; Differentiation of isolated human umbilical cord mesenchymal stem cells into neural stem cells. Int J Ophthalmol 2016,9(1),41-47","journal-title":"Int J Ophthalmol"},{"key":"ref=388","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/s41598-017-00298-2","volume":"7","author":"Zhang W.","year":"2017","unstructured":"Zhang W.; Wang Y.; Kong J.; Dong M.; Duan H.; Chen S.; Therapeutic efficacy of neural stem cells originating from umbilical cord-derived mesenchymal stem cells in diabetic retinopathy. Sci Rep 2017,7(1),408","journal-title":"Sci Rep"},{"key":"ref=389","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s13287-018-1059-y","volume":"9","author":"Elshaer S.L.","year":"2018","unstructured":"Elshaer S.L.; Evans W.; Pentecost M.; Lenin R.; Periasamy R.; Jha K.A.; Alli S.; Gentry J.; Thomas S.M.; Sohl N.; Gangaraju R.; Adipose stem cells and their paracrine factors are therapeutic for early retinal complications of diabetes in the Ins2Akita mouse. Stem Cell Res Ther 2018,9(1),322","journal-title":"Stem Cell Res Ther"},{"key":"ref=390","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.5966\/sctm.2015-0342","volume":"5","author":"Kim J.M.","year":"2016","unstructured":"Kim J.M.; Hong K.S.; Song W.K.; Bae D.; Hwang I.K.; Kim J.S.; Chung H.M.; Perivascular progenitor cells derived from human embryonic stem cells exhibit functional characteristics of pericytes and improve the retinal vasculature in a rodent model of diabetic retinopathy. Stem Cells Transl Med 2016,5(9),1268-1276","journal-title":"Stem Cells Transl Med"},{"key":"ref=391","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000492838","volume":"49","author":"Gu X.","year":"2018","unstructured":"Gu X.; Yu X.; Zhao C.; Duan P.; Zhao T.; Liu Y.; Li S.; Yang Z.; Li Y.; Qian C.; Yin Z.; Wang Y.; Efficacy and safety of autologous bone marrow mesenchymal stem cell transplantation in patients with diabetic retinopathy. Cell Physiol Biochem 2018,49(1),40-52","journal-title":"Cell Physiol Biochem"},{"key":"ref=392","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/B978-0-444-53480-4.00037-0","volume":"Vol. 126","author":"Greig M.","year":"2014","unstructured":"Greig M.; Tesfaye S.; Selvarajah D.; Wilkinson I.D.; Insights into the pathogenesis and treatment of painful diabetic neuropathy. Handbook of Clinical Neurology 2014,Vol. 126,559-578","journal-title":"Handbook of Clinical Neurology"},{"key":"ref=393","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11892-015-0609-2","volume":"15","author":"Kaku M.","year":"2015","unstructured":"Kaku M.; Vinik A.; Simpson D.M.; Pathways in the diagnosis and management of diabetic polyneuropathy. Curr Diab Rep 2015,15(6),35","journal-title":"Curr Diab Rep"},{"key":"ref=394","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.2337\/db08-0031","volume":"57","author":"Shibata T.","year":"2008","unstructured":"Shibata T.; Naruse K.; Kamiya H.; Kozakae M.; Kondo M.; Yasuda Y.; Nakamura N.; Ota K.; Tosaki T.; Matsuki T.; Nakashima E.; Hamada Y.; Oiso Y.; Nakamura J.; Transplantation of bone marrow-derived mesenchymal stem cells improves diabetic polyneuropathy in rats. Diabetes 2008,57(11),3099-3107","journal-title":"Diabetes"},{"key":"ref=395","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.expneurol.2016.11.006","volume":"288","author":"Monfrini M.","year":"2017","unstructured":"Monfrini M.; Donzelli E.; Rodriguez-Menendez V.; Ballarini E.; Carozzi V.A.; Chiorazzi A.; Meregalli C.; Canta A.; Oggioni N.; Crippa L.; Avezza F.; Silvani S.; Bonandrini B.; Figliuzzi M.; Remuzzi A.; Porretta-Serapiglia C.; Bianchi R.; Lauria G.; Tredici G.; Cavaletti G.; Scuteri A.; Therapeutic potential of mesenchymal stem cells for the treatment of diabetic peripheral neuropathy. Exp Neurol 2017,288,75-84","journal-title":"Exp Neurol"},{"key":"ref=396","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1161\/CIRCRESAHA.114.302854","volume":"114","author":"Suncion V.Y.","year":"2014","unstructured":"Suncion V.Y.; Ghersin E.; Fishman J.E.; Zambrano J.P.; Karantalis V.; Mandel N.; Nelson K.H.; Gerstenblith G.; DiFede Velazquez D.L.; Breton E.; Sitammagari K.; Schulman I.H.; Taldone S.N.; Williams A.R.; Sanina C.; Johnston P.V.; Brinker J.; Altman P.; Mushtaq M.; Trachtenberg B.; Mendizabal A.M.; Tracy M.; Da Silva J.; McNiece I.K.; Lardo A.C.; George R.T.; Hare J.M.; Heldman A.W.; Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally?: An analysis from the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) randomized trial. Circ Res 2014,114(8),1292-1301","journal-title":"Circ Res"},{"key":"ref=397","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1161\/CIRCRESAHA.114.303180","volume":"114","author":"Karantalis V.","year":"2014","unstructured":"Karantalis V.; DiFede D.L.; Gerstenblith G.; Pham S.; Symes J.; Zambrano J.P.; Fishman J.; Pattany P.; McNiece I.; Conte J.; Schulman S.; Wu K.; Shah A.; Breton E.; Davis-Sproul J.; Schwarz R.; Feigenbaum G.; Mushtaq M.; Suncion V.Y.; Lardo A.C.; Borrello I.; Mendizabal A.; Karas T.Z.; Byrnes J.; Lowery M.; Heldman A.W.; Hare J.M.; Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial. Circ Res 2014,114(8),1302-1310","journal-title":"Circ Res"},{"key":"ref=398","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jdermsci.2016.07.008","volume":"84","author":"Hu S.C.S.","year":"2016","unstructured":"Hu S.C.S.; Lan C.C.E.; High-glucose environment disturbs the physiologic functions of keratinocytes: Focusing on diabetic wound healing. J Dermatol Sci 2016,84(2),121-127","journal-title":"J Dermatol Sci"},{"key":"ref=399","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083314","volume":"8","author":"Tecilazich F.","year":"2013","unstructured":"Tecilazich F.; Dinh T.; Pradhan-Nabzdyk L.; Leal E.; Tellechea A.; Kafanas A.; Gnardellis C.; Magargee M.L.; Dejam A.; Toxavidis V.; Tigges J.C.; Carvalho E.; Lyons T.E.; Veves A.; Role of endothelial progenitor cells and inflammatory cytokines in healing of diabetic foot ulcers. PLoS One 2013,8(12)","journal-title":"PLoS One"},{"key":"ref=400","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1089\/cell.2015.0087","volume":"18","author":"Gerami-Naini B.","year":"2016","unstructured":"Gerami-Naini B.; Smith A.; Maione A.G.; Kashpur O.; Carpinito G.; Veves A.; Mooney D.J.; Garlick J.A.; Generation of induced pluripotent stem cells from diabetic foot ulcer fibroblasts using a nonintegrative sendai virus. Cell Reprogram 2016,18(4),214-223","journal-title":"Cell Reprogram"},{"key":"ref=401","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1172\/JCI82788","volume":"126","author":"Khamaisi M.","year":"2016","unstructured":"Khamaisi M.; Katagiri S.; Keenan H.; Park K.; Maeda Y.; Li Q.; Qi W.; Thomou T.; Eschuk D.; Tellechea A.; Veves A.; Huang C.; Orgill D.P.; Wagers A.; King G.L.; PKC&#x3B4; inhibition normalizes the wound-healing capacity of diabetic human fibroblasts. J Clin Invest 2016,126(3),837-853","journal-title":"J Clin Invest"}],"container-title":["Current Topics in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1568026623666221201150933","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/211496\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1568026623666221201150933","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T15:32:25Z","timestamp":1691335945000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/211496\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":401,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568026623666221201150933","relation":{},"ISSN":["1568-0266"],"issn-type":[{"value":"1568-0266","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-06-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}